Skip to main content

The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa

Abstract

Objective

In this study, we investigated the impact of COVID-19 NPIs in South Africa to understand their effectiveness in the reduction of transmission of COVID-19 in the South African population. This study also investigated the COVID-19 testing, reporting, hospitalised cases, excess deaths and COVID-19 modelling in the first wave of the COVID-19 epidemic in South Africa.

Methods

A semi-reactive stochastic COVID-19 model, the ARI COVID-19 SEIR model, was used to investigate the impact of NPIs in South Africa to understand their effectiveness in the reduction of COVID-19 transmission in the South African population. COVID-19 testing, reporting, hospitalised cases and excess deaths in the first COVID-19 epidemic wave in South Africa were investigated using regressional analysis and descriptive statistics.

Findings

The general trend in population movement in South African locations shows that the COVID-19 NPIs (National Lockdown Alert Levels 5,4,3,2) were approximately 30% more effective in reducing population movement concerning each increase by 1 Alert Level. The translated reduction in the effective SARS-CoV-2 daily contact number (β) was 6.12% to 36.1% concerning increasing Alert Levels. Due to the implemented NPIs, the effective SARS-CoV-2 daily contact number in the first COVID-19 epidemic wave in South Africa was reduced by 58.1–71.1% while the peak was delayed by 84 days. The estimated COVID-19 reproductive number was between 1.98 to 0.40. During South Africa’s first COVID-19 epidemic wave, the mean COVID-19 admission status in South African hospitals was 58.5%, 95% CI [58.1–59.0] in the general ward, 13.4%, 95% CI [13.1–13.7] in the intensive care unit, 13.3%, 95% CI [12.6–14.0] on oxygen, 6.37%, 95% CI [6.23–6.51] in high care, 6.29%, 95% CI [6.02–6.55] on ventilator and 2.13%, 95% CI [1.87–2.43] in isolation ward respectively. The estimated mean South African COVID-19 patient discharge rate was 11.9 days per patient. While the estimated mean of the South African COVID-19 patient case fatality rate (CFR) in hospital and outside the hospital was 2.06%, 95% CI [1.86–2.25] (deaths per admitted patients) and 2.30%, 95% CI [1.12–3.83](deaths per severe and critical cases) respectively. The relatively high coefficient of variance in COVID-19 model outputs observed in this study shows the uncertainty in the accuracy of the reviewed COVID-19 models in predicting the severity of COVID-19. However, the reviewed COVID-19 models were accurate in predicting the progression of the first COVID-19 epidemic wave in South Africa.

Conclusion

The results from this study show that the COVID-19 NPI policies implemented by the Government of South Africa played a significant role in the reduction of COVID-19 active, hospitalised cases and deaths in South Africa’s first COVID-19 epidemic wave. The results also show the use of COVID-19 modelling to understand the COVID-19 pandemic and the impact of regressor variables in an epidemic.

Peer Review reports

Introduction

The study of the occurrence of a disease is called epidemiology [1]. A disease is called a pandemic when there is a rapid increase of cases of the disease in a relatively short time and, a disease is endemic if it is within the population for a relatively long time. Diseases can be caused by various agents such as bacteria and viruses and transmitted by various modes, such as human-to-human contact, reservoir to vector to humans such as in malaria. Every disease has a specific agent and mode of transmission [1]. COVID-19 is the disease caused by the SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2). The 'CO' stands for corona, 'VI' for virus, and 'D' for disease. Formerly, this disease was referred to as the '2019 novel coronavirus' or '2019-nCoV.' [2, 3]. Coronaviruses are a large family of viruses that are attributed to causing mild respiratory infections such as the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS) [4]. The SARS-CoV-2 virus is a zoonotic virus belonging to the Betacoronavirus 2B lineage, similar to Coronaviruses found in bats and pangolins. Bats and pangolins are common reservoirs for Coronaviruses however, SARS-CoV-2 has not been isolated from bats or pangolins and there is a suspected inconclusive intermediate host in the initial transmission of the SARS-CoV-2 to humans [4, 5]. In December 2019 and January 2020, there was a cluster of cases of respiratory illnesses in the province of Wuhan City, Hubei Province, China. This cluster of cases was later determined to be caused by the SARS-CoV-2. The SARS-CoV-2 was identified and isolated on the 7th of January in China [6]. On January 30, 2020, the WHO declared the COVID-19 outbreak a global health emergency and on March 11, 2020, a global pandemic [7].

The SARS-COV-2’s main mechanism for host entry is through interactions with the host angiotensin-converting enzyme II (ACE2) located on the host cell’s surface. In humans, these enzymes are most abundant in the epithelia of the lungs and small intestines [8]. Hence an infection with SARS-COV-2 is characterised by respiratory illness/disease. The immune response to SARS-COV-2 in humans is thought to be both innate and adaptive. The innate response is attributed to the early symptoms of COVID-19 which are fevers and muscle aches [9]. SARS-COV-2 infections cause various symptoms such as coughing/sore throat, fever, myalgia or fatigue, respiratory symptoms, and pneumonia. In moderate disease, pneumonia is reported and becomes severe in severe cases. In critical cases, it can cause acute respiratory distress syndrome (ARDS), dyspnoea, respiratory failure, sepsis, septic shock, acute thrombosis and multiple organ failure [10,11,12]. It has been hypothesised that there might be an over-response by the immune system (Cytokine storm syndromes). The result is the generation of fluids and inflammation and damage to respiratory cells especially in severe and critical cases [13]. Severe and critical COVID-19 cases need assisted/mechanical breathing. Most COVID-19 patients who recovered developed antibodies to the SARS-CoV-2 virus within 1 to 3 weeks [9]. Even though recovered cases show the presence of late antibodies (IgG), there is still uncertainty in their titre levels and neutralisation for an effective immune response to a secondary SARS-CoV-2 infection. Some studies have shown the disappearance of neutralising antibodies reacting to SARS-COV-2 after 3 months [14, 15]. However, the adaptive immune response’s ability to produce memory cells (remaining T-cells and B-cells after primary infection) is unknown for COVID-19 [9]. SARS-CoV-2 is an RNA virus and RNA genetic material is prone to mutations however coronaviruses have the capacity for proofreading during replication which results in relatively lower rates of mutation [16]. Regardless of the capacity to proofread, there have been several reported variants of SARS-CoV-2 that have been identified since the outbreak. Some variants have raised concern about their impacts on transmissibility, and clinical characteristics, particularly in COVID-19 disease severity, diagnostics, therapeutics, and vaccines. Currently of note, are the SARS-CoV-2 variants B.1.1.7 (SARS-CoV-2 VOC 202012/01 first identified in the UK), B.1.351 (501Y.V2 first identified in South Africa) and P.1 (first identified in Brazil) [17]. There have been reports of increased transmissibility and reduced vaccine efficacy with some of the mentioned variants [18].

On the 5th of March 2020, South Africa reported its first cases of COVID-19 [19]. This signalled the onset of the first wave of the COVID-19 epidemic in South Africa where the number of reported cases started to increase exponentially. According to the data provided by the National Institute of Communicable Diseases (NICD), the first wave of the pandemic in South Africa lasted from 05 March 2020 to 1 October 2020. From 05 March to mid-June, the positivity rate stood at 0.02 cases per 100 000 people in the population per week and increased rapidly between mid-June and mid-July signalling the peak of the wave where the positivity rate had risen to 138.1 per 100 000 people in the population. During the first epidemic wave period, 676 084 confirmed COVID-19 cases had been reported and 16 866 reported deaths. More than 4.2 million tests had been conducted. Western Cape, KwaZulu-Natal and Gauteng provinces had the highest number of cases with the confirmed cases in these provinces accounting for more than 66.5% of the total reported cases in the country. Of the reported cases, 609 854 had been reported to have recovered from COVID-19 which translated to a recovery rate of 90.2% [20].

The response of governments in the wake of the COVID-19 pandemic was the use of non-pharmaceutical interventions (NPIs) [21]. NPIs are actions taken by a population to slow down the transmission of disease, apart from vaccination and medicinal treatment [22]. In an African context, a region with a relatively high disease burden, NPIs have played a significant role in controlling disease in the population. For example, in the case of the Cholera outbreak in Africa, citizens were informed to boil all naturally sourced water before drinking, have constant washing of hands and have proper disposal of human faecal matter. Sanitation played a significant role in containing the Cholera outbreak in Africa [23]. In the case of the HIV epidemic, a disease with a relatively high prevalence in the Southern African region, HIV epidemic needle and syringe programmes to prevent the sharing of needles were implemented in conjunction with increased condom distribution and use [24]. The Ebola outbreak in 2014 which was mostly reported in the Western African region, also saw the implementation of widespread encouragement of frequent hand washing, the avoidance of contact with infected individuals, screening and testing at borders, in addition to the wearing of full-body Personal Protective Equipment (PPE) when dealing with infected patients as well as with the deceased who had succumb to Ebola [25]. On a global scale, the use of NPIs can be referenced in the Influenza (H1N1) Pandemic of 1918. During this pandemic, worldwide, populations were confined to their residences, public gatherings were banned, schools and public institutions were closed, infected individuals were quarantined and widespread mask-wearing became the norm within a distanced public [26]. Significant parallels can be drawn between the implementation of NPIs in the COVID-19 pandemic and the Influenza Pandemic of 1918 due to the similar modes of transmission of the two diseases. Similar to the Influenza pandemic, in the early stages of the COVID-19 pandemic conclusions were reached that the “prevention of contact” was paramount in the management of the outbreak.

Of interest in this study is the response to the COVID-19 epidemic in South Africa. In South Africa, the Government of South Africa declared a state of disaster and created a National Coronavirus Command Council to oversee the COVID-19 outbreak [27]. There were several National Lockdown Alert Levels declared by the council to try to curb the rate of infection to avoid colossally overwhelming the South African health care system. These policies focused on limiting contact within the population through movement restrictions, curfews, limiting services, restriction of business and trade, isolation and quarantine of infected persons and use of PPE. The understanding of the COVID-19 policy response in South Africa and its impact can aid in the development of NPI policies in future epidemics, particularly in an African context. Epidemiological modelling can be a powerful tool to assist in understanding the scale of transmission, disease severity, and the effectiveness of NPIs for policy development, disease control and prevention. Epidemiological models provide the ability to predict the macroscopic behaviour of diseases using microscopic descriptions. One of the many ways used in modelling an epidemic is through deterministic (based on average characteristics of the population characteristics under study) and/or stochastic modelling (based on the randomness of the elements of the population) [28]. Stochastic modelling appears to be more accurate in evaluating real-life epidemic propagation, hence the most used and preferred [28]. Stochastic models can be classified into 3 main groups: The SI, SIS and SIR models [1]. These compartmentalise a population into classes as a function of time with the rates determined by the clinical and social characteristics of the disease in the population: The Susceptible class-(S) (these are individuals who have no effective immunity and have not been infected yet); Exposed class (E) (Individuals who have contracted the virus but are still not yet infectious); Infective class (I) (these are individuals who are infected and are infectious that is transmitting the disease to others) and Removed/Recovered (R) (these are individuals who have recovered from the disease with immunity, isolated or died). In the SI model infected individuals do not recover whilst in the SIS model individuals recover with no immunity and in the SIR model individuals recover with immunity [1].

COVID-19 has been widely modelled with variations of the SEIR model [29,30,31,32,33,34,35]. One of the earliest Global COVID-19 transmission models to be published was the Imperial College London COVID-19 Model [31, 36]. The Imperial College London COVID-19 Model had a great influence on the early policy response to COVID-19 in the United Kingdom and many other countries including countries in Africa [31]. Another COVID-19 Model of note was the model produced by One Health Trust formerly the Center for Disease Dynamics, Economics & Policy (CDDEP) [30, 32]. The CDDEP COVID-19 Models tried to understand the impact of Country-Wise Lockdowns (Frost, Craig, et al., 2020) and Health Care system preparedness in African countries [30]. South Africa received much attention concerning COVID-19 Modelling with several models being published and noted by the Government of South Africa [37]. Of note, are the National COVID-19 Epi Model (NCEM) and the National COVID-19 Cost Model (NCCM) by the South African COVID-19 Modelling Consortium, 2020. The NCEM is an SEIR stochastic compartmental transmission model that was developed to estimate the total and reported incidence of COVID-19 cases in South Africa up to November 2020 [38]. While the NCCM was a model developed to determine the COVID-19 response budget in South Africa. The NCEM and NCCM played a key role in South Africa’s early policy and planning response to COVID-19. While most of the mentioned COVID-19 models have been proactive, there is a need for semi-reactive models to help assess the post-COVID-19 epidemic with parameters derived from real reported case data. This allows for improvement in the accuracy of modelling parameters and outputs.

In this study, a semi-reactive COVID-19 model, the ARI COVID-19 SEIR model, was used to investigate the impact of NPIs in South Africa to understand their effectiveness in the reduction of transmission of COVID-19 in the South African population. This study also investigated the COVID-19 testing, reporting, hospitalised cases, excess deaths and COVID-19 modelling in the first wave of the COVID-19 epidemic in South Africa. The understanding of the NPIs developed in this study is aimed at assisting with early NPI policy development in South Africa and Africa for current and future epidemics.

Methodology

Model structure

To model the transmission dynamics of COVID-19 in the first COVID-19 epidemic wave in South Africa a stochastic compartmental transmission SEIR model was used hereafter called the “ARI COVID-19 SEIR” model. Figure 1 shows the structure of the ARI COVID-19 SEIR model. The ARI COVID-19 SEIR Model was constructed in a Macro-Enabled Microsoft (Ms) Excel File for user-friendliness (visual interaction with parameters) and Database Query Support. The Model had a Visual Basic Application (VBA) code for Sensitivity and Variable Analysis.

Fig. 1
figure 1

The ARI COVID-19 SEIR Model structure

Figure 1 shows that the ARI COVID-19 SEIR model had the following population classes based on the assumed clinical diagnosis of COVID-19 within the population:

  • Susceptible (S)-Individuals within the population of the model who can incur the disease however have not been infected yet.

  • Exposed (E)-Individuals within the population of the model in an incubation period who are not yet infectious.

  • Asymptomatic (Ia)-Individuals within the population of the model who are infected and are infectious that are transmitting the disease to others however are not showing any symptoms throughout their infectiousness.

  • Pre-symptomatic Infectious (Ip)-Individuals within the population of the model that are transmitting the disease during their incubation period.

  • Infected with Mild and Moderate Symptoms (Ib)-Individuals within the population of the model with mild and moderate symptoms who are infectious.

  • Infected with Severe and Critical Symptoms (Ic)-Individuals within the population of the model with severe and critical symptoms who are infectious however have not yet been hospitalised.

  • Hospitalised COVID-19 Cases (H)-Individuals within the population of the model with severe and critical symptoms who have been hospitalised.

  • Death due to COVID-19 (D)-Individuals who have died due to COVID-19 or indirect consequences of the COVID-19 epidemic.

  • Recovered (R)-Individuals within the population of the model who have recovered from the disease with immunity or partial immunity.

Model equations

The transmission and severity of COVID-19 within-population classes in the model were simulated using ordinary differential equations (ODEs). The differentiation in the ODEs was conducted using Euler’s method with 1-day estimation steps. The total population (N) in the model is represented by Eq. 1 based on the conservation of mass. Vitals (new births and non-COVID-19 deaths) were not considered in the model due to the relatively small annual growth rate of 1.40% in the South African population [39] and the low incidence of COVID-19 in neonatal [40]. The ARI COVID-19 SEIR model instead used the 2020 South African population estimates from the United Nations (UN) World Population Prospects [41]. The total infections are given by Eq. 2.

$$N=S+E+Ia+Ip+Ib+Ic+H+R+D$$
(1)
$$Iabc=Ia+Ip+Ib+Ic+H$$
(2)

The change in the susceptible population class is given by Eq. 3 where β is the Effective daily contact rate, this is the average number of adequate contacts per infective per day. The product of S and I in Eq. 3 is referred to as the mass incident term.

$$\frac{\partial S}{\partial t}=-A\beta S\frac{Iabc}{N}$$
(3)
$$A\;=\;-\frac{\displaystyle\frac{\displaystyle\frac{\sqrt{Country\;Area}}\pi}N}{Effective\;Social\;distance}\;+\;1$$
(4)

A is the Population density factor given by Eq. 4. Where the Effective Social distance is the minimum distance between the infector and infectee which prevents infection. For COVID-19 a distance of 2 m was assigned [42]. As the average distance between individuals tends towards the effective social distance, the Population Density Factor (A) tends towards 0. The Population Density Factor assumes a uniform distribution of the population within a confined area. The change in the exposed class is given by Eq. 5.

$$\frac{\delta E}{\delta t}= A\beta S\frac{Iabc}{N}-{k}_{1}{\xi }_{1}E-{k}_{2}{\xi }_{2}E$$
(5)

Where K1 and K2 are the rates at which exposed individual moves to the infected class. K1 is inversely proportional to the average incubation period of COVID-19 Asymptomatic Cases (Tinc,1) and K2 is inversely proportional to the average incubation period of COVID-19 Symptomatic Cases (Tinc,2) in the population. ξ1, ξ2, ξ3, ξ4 are the proportions of the exposed and pre-symptomatic who will be Asymptomatic (ξ1), Symptomatic (ξ2), Develop Mild and Moderate Symptoms (ξ3) and Severe and Critical Symptoms (ξ4), respectively.

$$\xi_1\;+\;\xi_2\;=\;1$$
(6)
$${\xi }_{3}+{\xi }_{4} =1$$
(7)

The change in the infectious class is given by Eqs. 8, 9, 10, 11 and 12.

$$\frac{\delta Ip}{\delta t}={k}_{2}{\xi }_{2}E-{\theta {\xi }_{3}I}_{p}-{\theta {\xi }_{4}I}_{p}$$
(8)

Equation 8 reduces to Eq. 9 by substituting Eq. 7.

$$\frac{\delta Ip}{\delta t}={k}_{2}{\xi }_{2}E-{\theta I}_{p}$$
(9)
$$\frac{\delta Ia}{\delta t}={k}_{1}{\xi }_{1}E-{\Upsilon }_{1}Ia$$
(10)
$$\frac{\delta Ib}{\delta t}={\theta {\xi }_{3}I}_{p}-{\Upsilon }_{2}Ib$$
(11)
$$\frac{\delta Ic}{\delta t}={\theta {\xi }_{4}I}_{p}-hIc-{\mu }_{o}Ic$$
(12)

The change in the Hospitalised, Death and Recovered class is given by Eqs. 13, 14, and 15, respectively.

$$\frac{\delta H}{\delta t}=hIc-{\Upsilon }_{3}H-\mu H$$
(13)
$$\frac{\delta D}{\delta t}=\mu H+{\mu }_{o}Ic$$
(14)
$$\frac{\delta R}{\delta t}={\Upsilon }_{1}Ia+{\Upsilon }_{2}Ib+{\Upsilon }_{3}H$$
(15)

Where, ϒ1, ϒ2 and ϒ3 are the daily recovery rates of individuals with Asymptomatic, Mild and Moderate Symptoms and Severe and Critical Symptoms, respectively. θ is the rate at which pre-symptomatic individuals develop symptoms. h is the rate at which individuals who have developed severe and critical cases are hospitalised. μo is the daily death rate due to direct and indirect effects of COVID-19 in individuals with severe and critical symptoms who have not been hospitalised. \(\mu\) is the daily death rate due to COVID-19 in hospitalised individuals.

$$\frac{\delta Iabc}{\delta t}=\frac{\delta Ia}{\delta t}+\frac{\delta Ip}{\delta t}+\frac{\delta Ib}{\delta t}+\frac{\delta Ic}{\delta t}+\frac{\delta H}{\delta t}$$
(16)
$$\frac{\delta Iabc}{\delta t}={k}_{1}{\xi }_{1}E-{\Upsilon }_{1}Ia+{k}_{2}{\xi }_{2}E-{\theta I}_{p}+{\theta {\xi }_{3}I}_{p}-{\Upsilon }_{2}Ib+{\theta {\xi }_{4}I}_{p}-hIc-{\mu }_{o}Ic+hIc-{\Upsilon }_{3}H-\mu H$$
(17)
$$\frac{\delta R}{\delta t}{=\Upsilon }_{1}Ia+{\Upsilon }_{2}Ib+{\Upsilon }_{3}Ic$$
(18)
$$\frac{\delta R}{\delta t}{=\Upsilon }_{1}\left(Ia+Ib+Ic\right)={\Upsilon }_{1}(Iabc)$$
(19)

Model basic reproductive number and herd immunity

For the feasible region in the octant of the mathematic model, there exists an equilibrium in which there is no disease called the Disease-Free Equilibrium (DFE). This condition is satisfied by the stability of the rate of change in the population. Thus:

$$\frac{\delta N}{\delta t}=\frac{\delta S}{\delta t}+\frac{\delta E}{\delta t}+\frac{\delta Ia}{\delta t}+\frac{\delta Ip}{\delta t}+\frac{\delta Ib}{\delta t}+\frac{\delta Ic}{\delta t}+\frac{\delta H}{\delta t}+\frac{\delta R}{\delta t}+\frac{\delta D}{\delta t}$$
(20)
$$\frac{\delta N}{\delta t}=-A\beta S\frac{Iabc}{N}+A\beta S\frac{Iabc}{N}-{k}_{1}{\xi }_{1}E-{k}_{2}{\xi }_{2}E+{k}_{1}{\xi }_{1}E-{\Upsilon }_{1}Ia+{k}_{2}{\xi }_{2}E-{\theta I}_{p}+{\theta {\xi }_{3}I}_{p}-{\Upsilon }_{2}Ib+{\theta {\xi }_{4}I}_{p}-hIc-{\mu }_{o}Ic+hIc-{\Upsilon }_{3}H-\mu H+\mu H+{\mu }_{o}Ic+ {\Upsilon }_{1}Ia+{\Upsilon }_{2}Ib+{\Upsilon }_{3}H$$
(21)
$$\frac{\delta N}{\delta t}=0$$
(22)
$$\frac{\delta N}{\delta t}\ge 0\ge S+E+Iabc+R+D$$
(23)

At Disease Free Equilibrium (DFE), E = 0, I = 0, R = 0, D = 0. Therefore, substituting DFE values into Eq. 23 gives Eq. 24.

$$\frac{\delta N}{\delta t}\ge 0\ge S$$
(24)

At each point in time in the model, there also exists an equilibrium in which there is a maximum/minimum for each class. This equilibrium is called the Endemic Equilibrium (EE). Thus, taking Eq. 3 and Eqs. 9, 10, 11, 12, 13, 14 and 15 where the rate of change is 0 gives Eqs. 25, 26, 27, 28, 29, 30, 31, 32 and 33

$$\frac{\partial S}{\partial t}=-A\beta S\frac{Iabc}{N}=0$$
(25)
$$\frac{\delta E}{\delta t}= A\beta S\frac{Iabc}{N}-{k}_{1}{\xi }_{1}E-{k}_{2}{\xi }_{2}E=0$$
(26)
$$\frac{\delta Ip}{\delta t}={k}_{2}{\xi }_{2}E-{\theta I}_{p}=0$$
(27)
$$\frac{\delta Ia}{\delta t}={k}_{1}{\xi }_{1}E-{\Upsilon }_{1}Ia=0$$
(28)
$$\frac{\delta Ib}{\delta t}={\theta {\xi }_{3}I}_{p}-{\Upsilon }_{2}Ib=0$$
(29)
$$\frac{\delta Ic}{\delta t}={\theta {\xi }_{4}I}_{p}-hIc-{\mu }_{o}Ic=0$$
(30)
$$\frac{\delta H}{\delta t}=hIc-{\Upsilon }_{3}H-\mu H=0$$
(31)
$$\frac{\delta D}{\delta t}=\mu H+{\mu }_{o}Ic=0$$
(32)
$$\frac{\delta R}{\delta t}={\Upsilon }_{1}Ia+{\Upsilon }_{2}Ib+{\Upsilon }_{3}H=0$$
(33)

Substituting Eq. 2731 into Eq. 2 gives Eq. 34.

$$Iabc=Ia+Ip+Ib+Ic+H= \frac{E{k}_{2}{\xi }_{2}}{\theta }+\frac{E{k}_{1}{\xi }_{1}}{{\Upsilon }_{1}}+\frac{{\theta {\xi }_{3}I}_{p}}{{\Upsilon }_{1}}+\frac{{\theta {\xi }_{4}I}_{p}}{(h+{\mu }_{o})}+\frac{hIc}{({\Upsilon }_{3}+\mu )}$$
(34)

Substituting Eqs. 27 and 30 into Eq. 34 gives Eq. 35.

$$Iabc=\frac{E{k}_{2}{\xi }_{2}}{\theta }+\frac{E{k}_{1}{\xi }_{1}}{{\Upsilon }_{1}}+\frac{{E{{\xi }_{2}\xi }_{3}k}_{2}}{{\Upsilon }_{2}}+\frac{{E{{\xi }_{2}\xi }_{4}k}_{2}}{(h+{\mu }_{o})}+\frac{h{E{{\xi }_{2}\xi }_{4}k}_{2}}{(h+{\mu }_{o})({\Upsilon }_{3}+\mu )}$$
(35)

From Eq. 26, making S the subject of the equation gives Eq. 36:

$$S=\frac{NE {(k}_{1}{\xi }_{1}+{k}_{2}{\xi }_{2})}{A\beta Iabc}$$
(36)

Substituting Eq. 35 into Eq. 36 gives Eq. 37.

$$S=\frac{N{(k}_{1}{\xi }_{1}+{k}_{2}{\xi }_{2}) \theta {\Upsilon }_{1}{\Upsilon }_{2}(h+{\mu }_{o})({\Upsilon }_{3}+\mu )}{A\beta ({k}_{2}{\xi }_{2}{\Upsilon }_{1}{\Upsilon }_{2} \left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+{k}_{1}{\xi }_{1}\theta {\Upsilon }_{2 }\left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+{k}_{2}{{\xi }_{2}\xi }_{3}\theta {\Upsilon }_{1 }\left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+ {k}_{2}{{\xi }_{2}\xi }_{4}\theta {\Upsilon }_{1 }{\Upsilon }_{2 }\left({\Upsilon }_{3}+\mu \right)+h{k}_{2}{{\xi }_{2}\xi }_{4}\theta {\Upsilon }_{1 }{\Upsilon }_{2}}$$
(37)

The relative critical point for the model is when DFE = EE. Using Eq. 24 and Eq. 36 we derive Eqs. 38, 39 and 40.

$$S=\frac{N{(k}_{1}{\xi }_{1}+{k}_{2}{\xi }_{2}) \theta {\Upsilon }_{1}{\Upsilon }_{2}(h+{\mu }_{o})({\Upsilon }_{3}+\mu )}{A\beta ({k}_{2}{\xi }_{2}{\Upsilon }_{1}{\Upsilon }_{2} \left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+{k}_{1}{\xi }_{1}\theta {\Upsilon }_{2 }\left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+{k}_{2}{{\xi }_{2}\xi }_{3}\theta {\Upsilon }_{1 }\left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+ {k}_{2}{{\xi }_{2}\xi }_{4}\theta {\Upsilon }_{1 }{\Upsilon }_{2 }\left({\Upsilon }_{3}+\mu \right)+h{k}_{2}{{\xi }_{2}\xi }_{4}\theta {\Upsilon }_{1 }{\Upsilon }_{2 }}\le N$$
(38)
$$\frac{N{(k}_{1}{\xi }_{1}+{k}_{2}{\xi }_{2}) \theta {\Upsilon }_{1}{\Upsilon }_{2}(h+{\mu }_{o})({\Upsilon }_{3}+\mu )}{A\beta ({k}_{2}{\xi }_{2}{\Upsilon }_{1}{\Upsilon }_{2} \left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+{k}_{1}{\xi }_{1}\theta {\Upsilon }_{2 }\left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+{k}_{2}{{\xi }_{2}\xi }_{3}\theta {\Upsilon }_{1 }\left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+ {k}_{2}{{\xi }_{2}\xi }_{4}\theta {\Upsilon }_{1 }{\Upsilon }_{2 }\left({\Upsilon }_{3}+\mu \right)+h{k}_{2}{{\xi }_{2}\xi }_{4}\theta {\Upsilon }_{1 }{\Upsilon }_{2 }}\le 1$$
(39)
$$1 \le {R}_{0}=\frac{A\beta ({k}_{2}{\xi }_{2}{\Upsilon }_{1}{\Upsilon }_{2} \left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+{k}_{1}{\xi }_{1}\theta {\Upsilon }_{2 }\left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+{k}_{2}{{\xi }_{2}\xi }_{3}\theta {\Upsilon }_{1 }\left(h+{\mu }_{o}\right)\left({\Upsilon }_{3}+\mu \right)+ {k}_{2}{{\xi }_{2}\xi }_{4}\theta {\Upsilon }_{1 }{\Upsilon }_{2 }\left({\Upsilon }_{3}+\mu \right)+h{k}_{2}{{\xi }_{2}\xi }_{4}\theta {\Upsilon }_{1 }{\Upsilon }_{2 })}{{(k}_{1}{\xi }_{1}+{k}_{2}{\xi }_{2}) \theta {\Upsilon }_{1}{\Upsilon }_{2}(h+{\mu }_{o})({\Upsilon }_{3}+\mu )}$$
(40)

Equation 40 is what is defined as the basic reproductive number (R0) for the ARI COVID-19 SEIR model. The basic reproductive number is the number of secondary infections that one infected person would produce in a fully susceptible population through the entire duration of the infectious period. R0 provides a threshold condition for the stability of the disease-free equilibrium point [1]. If R0 is greater than 1 then there is an endemic equilibrium thus there will be an epidemic. If R0 is less than 1 then the disease will die out and remain at a relatively low level to the population size. As can be seen from Eq. 40, R0 can be summarised as a ratio of the daily contact number over the daily recovery rate. It can also be defined by Eq. 41:

$$Ro=(Number\,of\,contacts\,per\,time)\times\,(Probability\,of\,transmission\,per\,contact)\times\,(Duration\,of\,Infection)$$
(41)

The basic reproductive number assumes a completely susceptible population however the infection productiveness of the population changes as infections increase. The effective reproductive number, Re, is the number of secondary infections that one infected person would produce through the entire duration of the infectious period. It can be estimated based on the susceptible class given by Eq. 42:

$$Re={R}_{0}\times S$$
(42)

Herd immunity is an important concept in epidemiology. Herd immunity is when the population has enough people immune such that the disease will not spread if it was suddenly introduced randomly into the population. Consider if α is the fraction immune due to vaccination/acquired immunity. Then Heard Immunity is given by Eq. 43:

$$Herd\,Immunity\,(\mathrm{\alpha })=(1-\frac{1}{Ro})$$
(43)

Model parameters

Determining the hospital discharge rate in South Africa

The average Daily Hospital Discharge Rate (ϒ3) in South Africa was calculated based on clinical information from admitted patients with laboratory-confirmed COVID-19 in selected hospitals in South Africa under the National Institute for Communicable Diseases (NICD) DATCOV surveillance system. The NICD sentinel hospital surveillance system was designed to monitor and describe trends of COVID-19 hospitalizations and the epidemiology of hospitalized patients in South Africa [43]. The number of hospitals reporting in the NICD DATCOV surveillance system increased in the reporting period. Initially, 204 Facilities were reported, and this increased to 434 Facilities by 4 September 2020 [44]. Therefore, caution was taken when taking averages between reporting case dates. The average Daily Hospital Discharge Rate (ϒ3) for COVID-19 patients was calculated using the Number of Discharged Alive and Admitted patients Data in the NICD DATCOV surveillance system from 24 May to 01 October 2020. Equation 44 was used to calculate the Daily Discharge:

$${Daily\,Discharge \left(n\right)}_{i+1}={Discharged\,Alive\,(n)}_{i+1}-{Discharged\,Alive\,(n)}_{i}$$
(44)

Where n is the number of patients and i is the reported case date.

The average Daily Hospital Discharge Rate (ϒ3) was then calculated using Eq. 45.

$$\gamma_3\;=\;\frac{\overline{Daily\;Discharge{\;\left(n\right)}_{i+1}}}{Admitted_{i+1}}$$
(45)

Determining the death rate in hospitalised cases in South Africa

The average Daily Death Rate or Daily Case Fatality Rate (CFR) for COVID-19 patients (μ1) was calculated using the Number of Daily Deaths and Admitted patients Data in the NICD DATCOV surveillance system from 24 May-01 October 2020. The WHO guideline in estimating the CFR in [45] was followed. Equation 46 was used to calculate the Daily Deaths:

$${Daily\,Deaths\,\left(n\right)}_{i+1}={Died\,(n)}_{i+1}-{Died\,(n)}_{i}$$
(46)

where n is the number of patients and i is the reported case date.

The Daily Case Fatality Rate (CFR) for COVID-19 patients (μ) was then calculated using Eq. 47.

$$\mu\;=\;\frac{\overline{Daily\;Deaths\;{\left(n\right)}_{i+1}}}{{Admitted}_{i+1}}$$
(47)

Determining the death rate of unreported severe and critical cases in South Africa

Excess mortality is a count of deaths from all causes relative to what would normally have been expected. Excess mortality/deaths allow for accounting for miscounted or underreported COVID-19 Deaths and indirect Deaths related to the COVID-19 pandemic. National statistical agencies publish weekly deaths and averages of past ‘normal’ deaths [46]. In South Africa, the South African Medical Research Council (SAMRC) published the Excess deaths from 29 December 2019 to 01 October 2020 using information obtained from the National Population Register [47, 48]. The Unreported Excess Deaths (Natural) to COVID-19 Death Ratio was calculated for the period, 25 March to 01 October 2020 with data from [47] using Eq. 48:

$$Unreported\,Excess\,Deaths\,(Natural)\,to\,COVID-19\,Death\,Ratio=\frac{Excess\,Deaths\,(Natural)i-{Weekly\,Reported\,COVID-19\,Deaths }_{i}}{{Weekly\,Reported\,COVID-19\,Deaths }_{i}}$$
(48)

where i is the Weekly Reported Date. The daily death rate due to direct and indirect effects of COVID-19 in individuals with severe and critical symptoms who have not been hospitalised (μo) was then calculated using Eq. 49:

$${\upmu }_{o}=\stackrel{-}{Unreported\,Excess\,Deaths\,\left(Natural\right)\,to\,COVID-19\,Death\,Ratio}\times\,{\upmu }_{1}$$
(49)

Determining the COVID-19 patient admission status in South Africa

The average admission status for COVID-19 patients was calculated using the Number of patients Currently in Hospital (n), General Ward (n), High Care (n), Intensive Care Unit (n), Isolation Ward (n), On Oxygen (n) and On Ventilator (n) Data in the NICD DATCOV surveillance system from 24 May-1 October 2020. The average admission Status was calculated using Eqs. 50, 51, 52, 53, 54 and 55:

$$\mathrm{General\,Ward }(\mathrm{\%})=\overline{\frac{{\mathrm{General\,Ward\,}\left(\mathrm{n}\right)}_{i}}{{\mathrm{Currently\,in\,Hospital\,}(\mathrm{n})}_{i}}}\times 100$$
(50)
$$\mathrm{High\,Care }(\mathrm{\%}) =\overline{\frac{{\mathrm{High\,Care\,}(\mathrm{n}) }_{i}}{{\mathrm{Currently\,in\,Hospital\,}(\mathrm{n})}_{i}}}\times\,100$$
(51)
$$\mathrm{Intensive\,Care\,Unit\,}(\mathrm{\%})=\overline{\frac{{\mathrm{Intensive\,Care\,Unit\,}(\mathrm{n}) }_{i}}{{\mathrm{Currently\,in\,Hospital\,}(\mathrm{n})}_{i}}}\times 100$$
(52)
$$\mathrm{Isolation\,Ward\,}(\mathrm{\%})=\overline{\frac{{\mathrm{Isolation\,Ward\,}(\mathrm{n})}_{i}}{{\mathrm{Currently\,in\,Hospital\,}(\mathrm{n})}_{i}}}\times 100$$
(53)
$$\mathrm{On\,Oxygen }(\mathrm{\%}) =\overline{\frac{{\mathrm{On\,Oxygen\,}(\mathrm{n})}_{i}}{{\mathrm{Currently\,in\,Hospital\,}(\mathrm{n})}_{i}}}\times 100$$
(54)
$$\mathrm{On\,Ventilator\,}(\mathrm{\%}) =\overline{\frac{{\mathrm{On\,Ventilator\,}(\mathrm{n})}_{i} }{{\mathrm{Currently\,in\,Hospital\,}(\mathrm{n})}_{i}}}\times 100$$
(55)

The admission status was then calculated using the Hospitalised Cases (H) in the model with Eq. 56:

$$\mathrm{Admitted }\left(\mathrm{n}\right) =Admitted\,(\%)\times H$$
(56)

where the Admitted (%) is the General Ward (%), High Care (%), Intensive Care Unit (%), Isolation Ward (%), On Oxygen (%) and Ventilator (%) respectively. A summary of the model parameters used in the ARI-COVID-19 Model is given in Table 1:

Table 1 ARI COVID-19 SEIR model parameters for the South African first COVID-19 epidemic wave

Model NPI scenarios and seeding

Modelling periods and reported case data

To model the impact of NP1s in South Africa, the National Lockdown Alert Level 5, 4, and 3 policies implemented by the South African government were modelled as scenarios in the ARI COVID-19 SEIR model, respectively. A “No lockdown” scenario where there was no policy response from the South African government was also modelled in the ARI COVID-19 SEIR model.

In each scenario, the ARI COVID-19 SEIR model was seeded using COVID-19 deaths with the Unreported Excess Deaths (Natural) to COVID-19 Death Ratio used to account for excess deaths in the National Lockdown Alert Level 3 scenario. For the “No lockdown” Scenario, reported active cases were used to seed the model due to no reported COVID-19 and Excess (Natural) Deaths in this period. Table 2 shows the model classification of the South African COVID-19 policy and the seeding period used in the model.

Table 2 South Africa COVID-19 Policy response and Period Implemented, Model Classification and Model Seeding Period

Cumulative Daily Reported COVID-19 Case, Recovery and Death Data for South Africa were obtained from the Johns Hopkins University (JHU) Center for Systems Science and Engineering (CSSE) COVID-19 Database [56] for the period of 22 January 2020 to 1 October 2020. Since reported case data come after a period of clinical diagnosis, reported case dates thus are lagged from the “real-time” date of infection. Therefore, an Average Date of infection date was estimated using Eq. 57:

$$Average\,Date\,of\,Infection=Reported\,Case\,Date-Average\,Time\,for\,Clinical\,Diagnosis$$
(57)

where the Average time for Clinical diagnosis (Ttesting) is the average time taken for an infected person to be diagnosed and the diagnosis outcome to be classified and reported as a COVID-19 case. The COVID-19 Active Cases were determined using Eq. 58:

$$Active\,Cases=Sum\,of\,Cases-Sum\,of\,Recovered\,Cases-Sum\,of\,Deaths$$
(58)

Regression and statistical analysis

To seed the model, a non-linear regression analysis was conducted between the Reported COVID-19 Deaths and Death due to COVID-19 (D) from the model for the model seeding periods stated in Table 2. Seeding the Models with points that are oversensitive results in large deviations between modelled data versus reported case data. This deviation or noise introduced by “over-sensitive” data points creates a significant error in the model results. Thus, it was important to decide which Data points can be used in the regression analysis. For the modelling of NPIs, this was particularly important at the start of the pandemic when data values are relatively small. To decide on seeding data points, a Data Point Sensitivity term described by Eq. 59 was used:

$$\mathrm{Data\,Point\,Sensitivity}=\frac{\mathrm{Active\,Case\,or\,Reported\,COVID}-19\mathrm{\,Deaths }}{Lowest\,Possible\, Data\,Unit}$$
(59)

where the Lowest Possible Data unit is the lowest possible unit of measurement for that data. In this case, it is 1 COVID-19 Reported Case. Data points with a Data Point Sensitivity greater than 5% were ignored in the regression analysis. To conduct the regression analysis, the Residual and Normalised Errors were determined using Eq. 60 and Eq.  61:

$$Residual=Modelled\,Data- \mathrm{Active\,Case\,Data}/\mathrm{Reported\,COVID}-19\mathrm\,{ Deaths}$$
(60)
$$Normalised\,Error=\frac{Residual}{Active\,Cases\,or\,Reported\,COVID-19\,Deaths}$$
(61)

To allow the goodness of fit of Modelled data to Active Case or Reported COVID-19 Deaths Data, the Average Normalised Error of all Data points used in the Regression Analysis was reduced to 0 by changing the Effective Daily Contact Number (β) using the What-If Analysis Function in MS Excel. The pooled sample variance (s2) was then calculated using Eq. 62:

$${s}^{2}=\frac{\sum_{i=1}^{n1}{(xi-\overline{x1 })}^{2}+\sum_{i=1}^{n1}{(xj-\overline{x2 })}^{2}}{n1+n2-2}$$
(62)

Where xi is the Reported Case Data points, \(\overline{x1 }\) is the Reported Case Data Points Mean, xj is the Model Data points, \(\overline{x2 }\) is the Model Data Points Mean, n1 and n2 are the sample sizes. The t-value: Two-Sample Assuming Equal Variance was used to calculate the t-value using Eq. 63

$$t=\frac{\overline{x1 }-\overline{x2}}{\sqrt{{s }^{2} (\frac{1}{n1}+\frac{1}{n2})}}$$
(63)

For the No lockdown scenario, since reported active cases were used to seed this model scenario, a sensitivity analysis was run to determine the fraction of reported cases that are pre-symptomatic, mild & moderate, asymptomatic, and critical & severe. This was done using a VBA code following the computational steps outlined in Fig. 2.

Fig. 2
figure 2

ARI COVID-19 SEIR Model Scenario Statistical Analysis Computational Steps

The combination of the Φ1 Φ2 Φ3 Φ4 that resulted in the lowest T-value (most significance) between model data and reported case data for the No Lockdown Scenario are shown in Table 3 and were chosen to seed the No Lockdown Scenario.

Table 3 Fraction of Pre-symptomatic, Mild & Moderate, Asymptomatic and Critical & Severe in Reported Cases

For other Model Scenarios (South Africa National Lockdown Alert Level 5, 4 and 3), Reported COVID-19 Deaths were used to seed the Models. However, for the National Lockdown Alert Level 3 the reported COVID-19 deaths were adjusted to include unreported COVID-19 Deaths using Eq. 64:

$$Reported\ COVID-19\,Deaths\ \left(Seed\right)=Reported\ COVID-19\ Deaths+Reported\ COVID-19\ Deaths\times \stackrel{-}{Unreported\ Excess\ Deaths\ \left(Natural\right)\ to\ COVID-19\ Death\ Ratio}$$
(64)

Validation and limitations of model

The functionality and data produced by the ARI COVID-19 SEIR model were validated using the following:

  • For model functionality, the model ODEs were validated by setting the model scenario reproductive number (Ro) to 1 by changing the Effective Daily Contact Number (β) using the What-If Analysis Function in MS Excel. At Ro = 1, there should be no transmission of the population between model classes and model class values should be either at initial values or 0.

  • For model data, a comparison between COVID-19 Admitted data in the NICD DATCOV surveillance system and Hospitalised COVID-19 Cases (H) in the model. Comparison between Excess (Natural) deaths data and Death due to COVID-19 (D) in the model. Comparison between the reported date of peak Active cases and Total infections (Iabc) in the model. Comparison between the ARI COVID-19 SEIR Model results and results from the South Africa National COVID-19 Epi Model (NCEM), the Center for Disease Dynamics, Economics & Policy (CDDEP) COVID-19 Model and the Imperial College London COVID-19 Model.

The following limitations were identified during the modelling:

  • A non-linear regression analysis could not be conducted for the National Lockdown Alert Levels 2 and 1 due to these policies being implemented in the negative exponential phase of the first COVID-19 epidemic wave in South Africa. The limitation of non-linear regression analysis in the negative exponential phase of an epidemic is that the decrease in cases is not only due to a reduction in contact but also due to the reduction in the susceptibles and increase in the recovered cases in the population (decrease in the mass incident term) at disease-free equilibrium.

  • There was a limitation in determining the CFR in South Africa during the no-lowdown period before the first COVID-19 epidemic wave via regression analysis due to the low number of reported COVID-19 and excess deaths. The CFR could have been adjusted using functions that relate to active COVID-19 cases however such functions are limited. There was also a limitation in using the CFR to seed the model for the no lock down scenario hence active COVID-19 cases were used instead.

  • In this study, bootstrapping was not performed to estimate the variance of the ARI COVID-19 SEIR Model Effective Daily Contact Number (β) due to the small sample size used in the model seeding period.

  • Pharmaceutical interventions were not accounted for in the model.

  • The COVID-19 NPIs investigated in this study were limited to the National Lockdown Alert Levels.

  • The NPIs investigated in this model were a collection of measures of the National Lockdown Alert Levels. Individual NPI measures in the National Lockdown Alert Levels could not be modelled individually due to limited data.

Results

Impact of South African COVID-19 NPIs on movement and effective SARS-CoV-2 daily contact number

Table 4 shows a summary of the National Lockdown Alert Level policies implemented by the South African government during the duration of the first COVID-19 epidemic wave in South Africa. The National Lockdown Alert Levels were implemented under South Africa’s Disaster Management Act, 2002 (Act NO. 57 of 2002) [57]. The first COVID-19 case in South Africa was reported on the 5th of March 2020 [19]. For the first 20 days after the first reported case in South Africa, there was no NPI COVID-19 policy implemented however the country geared towards policy implementation by declaring a state of emergency and establishing a National Coronavirus Command Council to oversee the COVID-19 pandemic in South Africa. The first stringent measure initiated by the Council was a National Lockdown Level Alert 5 to try to curb the rate of infection to avoid colossally overwhelming the South African health care system. The National Lockdown Level Alert 5 was declared from the 26th of March 2020 to the 15th of April 2020 and then extended to the 30th of April 2020. The South African National Lockdown Level Alert 5 as shown in Table 4 was predominantly movement restrictions and limitation of services to essential services. Under this level, the South African borders and air space were closed, and there was an enforcement of strict non-movement of non-essential personnel and a ban on some of the industries such as the alcohol and tobacco industries. To enforce this policy the South African Defence Force was deployed to oversee the compliance of this measure (Government of South Africa, 2020b). A screening and testing program for COVID-19 was initiated by the South African Department of Health. The initial testing was conducted by the National Institute of Communicable Disease (NICD) and this was expanded to a larger network of private and National Health Laboratory Services (NHLS) (NICD, 2020b). Mobile testing units were also deployed particularly to the hardest-hit provinces of Gauteng, Western Cape and Kwa-Zulu Natal (Government of South Africa, 2020c). The South African economy like in many other countries with similar COVID-19 measures was negatively affected due to limitations in business and trade [58]. South Africa gradually eased restrictions to the National Lockdown Level Alerts 4,3,2 and 1 by permitting businesses to trade, easing curfews, and gathering capacity and movement restrictions as shown by the difference in the Alert Level policy summaries provided in Table 4. On the 17th of August 2020, the national lockdown alert level was adjusted to level 1 allowing for normal activities to resume with the strict condition of hygiene protocols being followed.

Table 4 South African National Lockdown Alert Level Policy Implemented in the Period of the First National COVID-19 Epidemic Wave [27, 59,60,61,62,63]

Figure 3 shows the South African Google Community Mobility Report in retail and recreation, grocery and pharmacy, parks, transit stations, workplaces and residences during the period of 2020/02/15 to 2020/10/01. The Google Community Mobility Reports are aimed at providing an understanding of the change in community movement in response to COVID-19 policies. The reports are generated using Google account information from people’s devices who have location history turned on [64].

Fig. 3
figure 3

South African Community Google Mobility in Retail and Recreation, Grocery and Pharmacy, Parks, Transit Stations, Workplaces and Residences during the period of 2020/02/15 to 2020/10/01 [64]

Figure 3 shows that there was a spike of 34% and 53% from baseline in the South African grocery and pharmacy locations on the 25th and 26th of March 2020 respectively. These dates correspond to 1 day prior and a day into the implementation of the National Lockdown Alert Level 5. Figure 3 shows that implementation of the National Lockdown Alert Level 5 resulted in an increase in movement in the South African residential location by 33 ± 6% from baseline while the retail and recreation, grocery and pharmacy, parks, transit stations, and workplaces locations decreased by -73 ± 4%, -46 ± 9%,-47 ± 7%,-78 ± 2% and -66 ± 12% respectively. Implementation of the National Lockdown Alert Level 4 resulted in a decrease in movement in the South African residential location compared to the Alert Level 5 by 10% (23 ± 5% from baseline). The National Lockdown Alert Level 4 resulted in a decrease in movement in the retail and recreation, grocery and pharmacy, parks, transit stations, and workplaces locations by -50 ± 5%, -23 ± 5%,-39 ± 7%,-62 ± 4% and -41 ± 15% from baseline respectively. Figure 3 shows that the implementation of the National Lockdown Alert Level 3 resulted in a lower movement in the South African residential location compared to the Alert Level 4 by 6% (17 ± 4% from baseline). The National Lockdown Alert Level 3 resulted in a decrease in movement in the retail and recreation, grocery and pharmacy, parks, transit stations, and workplaces locations by -30 ± 7%, -11 ± 7%,-23 ± 7%,-50 ± 5% and -28 ± 14% from baseline respectively. The implementation of the National Lockdown Alert Level 2 resulted in a lower movement in the South African residential location compared to the Alert Level 3 by 5% (12 ± 3% from baseline). The National Lockdown Alert Level 2 resulted in a decrease in movement in the retail and recreation, grocery and pharmacy, parks, transit stations, and workplaces locations by -19 ± 4%, -6 ± 5%,-14 ± 4%,-40 ± 4% and -22 ± 10% from baseline respectively. The implementation of the National Lockdown Alert Level 1 resulted in a decrease in movement in the retail and recreation, grocery and pharmacy, parks, transit stations, and workplaces locations by -19 ± 5%, -3 ± 8%,-21 ± 13%,-37 ± 5% and -26 ± 17% from baseline respectively.

Table 5 shows the ARI COVID-19 SEIR Model effective daily contact number (β), observations (Obs), pooled variance, degree of freedom (df), t-statistical value (t Stat), P-value (P (T <  = t) two-tail), t-Critical value, reduction in β for the hypothesized mean difference of 0 between reported case data and ARI COVID-19 Model Data at a P-value of 0.05 for South Africa No Lockdown, National Lock Down Alert Level 5,4 and 3 Scenarios. The results in Table 5 were determined using non-linear regression analysis. The ARI COVID-19 SEIR Model Residual (Normalised Error) and Statistical Regression Plots between Model Data and Seeding Reported Case Data are shown in Figure A.1-A.8 in the Supplementary Material section. The t Stat, P (T <  = t) two-tail and t Critical two-tail values in Table 5 show that the Model and Reported Case Data used in the seeding period for the No lockdown, National Lockdown Alert Level 5 and National Lockdown Alert Level 4 were not statistically significantly different (P = 0.785–0.911). Statistically significant differences ( P = 0.00382) were seen between the Model and Reported Case Data used in the seeding period for the National Lockdown Alert Level 3 due to the ARI Model accounting for excess deaths.

Table 5 ARI COVID-19 SEIR Model Effective Daily Contact Number (β), Observations (Obs), Pooled Variance, Degree of Freedom (df), t-statistical value (t Stat), P-Value (P (T <  = t) two-tail), t-Critical value, Reduction in β for the hypothesized mean difference of 0 between Reported Case Data and ARI COVID-19 Model Data at P-value = 0.05 for South Africa No Lockdown, National Lock Down Alert Level 5,4 and 3 Scenarios

First COVID-19 epidemic wave testing data in South Africa

Table 6 shows the mean COVID-19 daily testing capacity in South Africa, reported test positivity, cumulative tests, and tests per million for the period reported from 2020/02/07 to 2020/10/01. Table 6 shows that the cumulative COVID-19 tests for the period reported from 2020/02/07 to 2020/10/01 were 5 383 078 COVID-19 tests. According to the NICD, in the period reported from 2020/03/01 to 2020/10/03, there were 3 705 951 laboratory tests for SARS-COV-2 conducted nationally [65]. Table 6 also shows that the mean COVID-19 testing capacity per day in South Africa for the first COVID-19 epidemic wave was 18 069 ± 13 760 COVID-19 tests. The cumulative reported COVID-19-positive cases to test in South Africa for the first COVID-19 epidemic wave was 14.7%.

Table 6 South African Average COVID-19 Daily Testing Capacity, Reported Test Positivity, Cumulative Tests, Test per Million for the period 2020/02/07 to 2020/10/01 [66]

Figure 4 shows the South African COVID-19 daily testing and cases for the period reported from 2020/02/07 to 2020/10/01. Figure 4 shows that the COVID-19 testing in South Africa fluctuated daily during the first COVID-19 epidemic wave. The general trend shows a positive correlation between COVID-19 testing and cases in the first COVID-19 epidemic wave in South Africa.

Fig. 4
figure 4

South African COVID-19 Daily Testing and Cases for the period 2020/02/07 to 2020/10/01 [66]

First COVID-19 epidemic wave reported case data in South Africa

Figure 5 shows the cumulative, recovered and active COVID-19 cases and deaths in South Africa for the period reported from 2020/01/22 to 2020/10/01. Figure 6 shows that the first COVID-19 epidemic wave in South African provinces had different amplitudes and periods. Table 7 shows the provincial South African population, COVID-19 date of peak and peak active cases for the period reported from 2020/01/22 to 2020/10/01.

Fig. 5
figure 5

National Cumulative, Recovered and Active COVID-19 cases and deaths in South Africa for the period 2020/01/22 to 2020/10/01[56]

Fig. 6
figure 6

Active Provincial COVID-19 cases in South Africa for the period 2020/01/22 to 2020/10/01 [67]

Table 7 Provincial South African Population, Peak COVID-19 Date of Peak and Active Cases for the period 2020/01/22 to 2020/10/01 [67]

First COVID-19 epidemic wave hospitalised cases and deaths in South Africa

Figure 7 shows the admission status of COVID-19 patients in South African hospitals reported in the NICD DATCOV surveillance system during the period of 2020/05/24 to 2020/10/01. Figure 7 shows that the number of admitted patients increased from the period of 2020/05/24 to 2020/08/01 reaching a peak and then decreasing thereafter. The peak of admitted COVID-19 patients in South African hospitals corresponds with the peak of active COVID-19 cases observed in South Africa shown in Table 7.

Fig. 7
figure 7

South African COVID-19 Hospitalised Admission Status: Currently in Hospital, General Ward, High Care, Intensive Care Unit, Isolation Ward, On Oxygen, On Ventilator for the period of 2020/05/24 to 2020/10/01 [44]

Table 8 shows the mean, standard deviation (STDev), standard error of the mean (SE), and lower and upper confidence interval at a P-value of 0.05 for the COVID-19 discharge rate, hospitalised and the un-hospitalised fatality rate in South Africa for the period of 2020/05/24 to 2020/10/01.

Table 8 Mean, Standard Deviation (STDev), Standard Error of Mean (SE), Lower and Upper Confidence Interval at P-Value = 0.05 for the COVID-19 Discharge (Tdisch), Hospitalised (μ1) and un-hospitalised Fatality Rate (μo) in South Africa for the period of 2020/05/24 to 2020/10/01

Figure 8 shows a linear regression analysis done on the daily cumulative COVID-19 deaths and discharged patients in South African hospitals in the NICD DATCOV surveillance system for the period of 2020/05/24 to 2020/10/01. Figure 8 shows that cumulative COVID-19 deaths and discharged patients had a positive linear correlation with the reported case date. The correlation coefficient (R2) of the COVID-19 deaths and discharged patients with the reported case date was 0.9708 and 09675 respectively. A plot of the daily CFR and discharge rate in South African hospitals in the period of 2020/05/24 to 2020/10/01 is shown in Figure A.9.

Fig. 8
figure 8

Linear regression of South African COVID-19 Hospitalised Case Fatality and Discharge Rate for the period of 2020/05/24 to 2020/10/01 [44]

Fig. 9
figure 9

South African Weekly Excess (Natural) and COVID-19 Reported Deaths for the period of 2019/12/29–2020/10/01 [47, 48]

Table 9 shows the mean, standard deviation (STDev), standard error of the mean (SE), and lower and upper confidence interval at P-value = 0.05 for the proportion of COVID-19 admission status in South African hospitals for the period of 2020/05/24 to 2020/10/01. A plot of the daily proportion of the COVID-19 admission status in South African hospitals in the period of 2020/05/24 to 2020/10/01 is shown in Figure A.10.

Table 9 Mean, Standard Deviation (STDev), Standard Error of Mean (SE), Lower and Upper Confidence Interval at P-Value = 0.05 for the South African COVID-19 Hospital Admission Status for the period of 2020/05/24 to 2020/10/01
Fig. 10
figure 10

South African Excess to COVID-19 Death Ratio for the period from 2020/03/29 to 2020/10/01

Table 10 shows the mean, standard deviation (STDev), standard error of the mean (SE), and lower and upper confidence Interval at P-value = 0.05 for the COVID-19 hospitalised case age profile in South African hospitals for the period of 2020/05/24 to 2020/10/01. A plot of the daily proportion of COVID-19 case age group profiles in South African hospitals in the period of 2020/05/24 to 2020/10/01 is shown in Figure A.11.

Table 10 Mean, Standard Deviation (STDev), Standard Error of Mean (SE), Lower and Upper Confidence Interval at P-Value = 0.05 for the South African COVID-19 Hospitalised Case age profile for the period of 2020/05/24 to 2020/10/01
Fig. 11
figure 11

ARI COVID-19 SEIR Model Total COVID-19 Cases in the South African First COVID-19 Epidemic Wave for the No Lockdown, Hard Lockdown (National Lockdown Alert Level 5), Moderate Lockdown (National Lockdown Alert Level 4) and Soft Lockdown (National Lockdown Alert Level 3) scenarios

Table 11 shows the mean, standard deviation (STDev), standard error of the mean (SE), and lower and upper confidence interval at P-Value = 0.05 for the hospitalised COVID-19 death age profile in South African hospitals for the period of 2020/05/24 to 2020/10/01. A plot of the daily proportion of the COVID-19 death age group profile in South African hospitals in the period of 2020/05/24 to 2020/10/01 is shown in Figure A.12.

Table 11 Mean, Standard Deviation (STDev), Standard Error of Mean (SE), Lower and Upper Confidence Interval at P-Value = 0.05 for the South African hospitalised COVID-19 Death Age profile for the period of 2020/05/24 to 2020/10/01
Fig. 12
figure 12

ARI COVID-19 SEIR Model Symptomatic COVID-19 Cases in the South African First Epidemic Wave for the No Lockdown, Hard Lockdown (National Lockdown Alert Level 5), Moderate Lockdown (National Lockdown Alert Level 4) and Soft Lockdown (National Lockdown Alert Level 3) scenarios

Table 12 shows the cumulative COVID-19 death risk ratio for hospitalised age groups (Age Group 0–9 as reference (Ref)) in South African hospitals at a P-value of 0.05 for the period of 2020/05/24 to 2020/10/01.

Table 12 Cumulative COVID-19 Death Risk Ratio for hospitalised age groups (Age Group 0–9 as reference (Ref)) in South Africa at P-Value = 0.05 for the period of 2020/05/24 to 2020/10/01

Excess (Natural) Deaths during the First COVID-19 Epidemic Wave in South Africa

Figure 9 shows the weekly excess (natural) and COVID-19 reported deaths in South Africa for the period of 2019/12/29 to 2020/10/01. Figure 9 shows that the first reported COVID-19 death in South Africa was on the 15th of March 2020. Excess (Natural) deaths in South Africa started to exceed reported COVID-19 deaths in the weekly report on the 14th of June 2020. A plot of the Cumulative Excess (Natural) Deaths and COVID-19 Reported Deaths in South Africa for the period of 2019/12/29–2020/10/01 is shown in Figure A.13.

Fig. 13
figure 13

ARI COVID-19 SEIR Model Effective Reproductive Number in the South African COVID-19 First Epidemic Wave for the No Lockdown, Hard Lockdown (National Lockdown Alert Level 5), Moderate Lockdown (National Lockdown Alert Level 4) and Soft Lockdown (National Lockdown Alert Level 3) scenarios

Table 13 shows the mean, standard deviation (STDev), standard error of the mean (SE), and lower and upper confidence interval at a P-Value of 0.05 for weekly excess deaths, excess (natural) to natural deaths and excess deaths (natural) to COVID-19 death ratio in South Africa for the period from 2019/12/29 to 2020/10/01.

Table 13 Mean, Standard Deviation (STDev), Standard Error of Mean (SE), Lower and Upper Confidence Interval at P-Value = 0.05 for South African Weekly, Excess Deaths, Excess (Natural) to Natural Deaths and Excess Deaths (Natural) to COVID-19 Death Ratio for the period from 2019/12/29 to 2020/10/01

Figure 10 shows the South African excess to COVID-19 death ratio for the period from 2020/03/29 to 2020/10/01. Figure 10 shows that the excess to COVID-19 death ratio increased as the COVID-19 active cases in South Africa increased reaching a peak at the peak of the first COVID-19 epidemic wave and then decreasing thereafter.

Estimated COVID-19 cases, effective reproductive number during the first COVID-19 epidemic wave in South Africa

Figure 11 shows the ARI COVID-19 SEIR model total COVID-19 cases in the South Africa’s first COVID-19 epidemic wave for the no lockdown, hard lockdown (National Lockdown Alert Level 5), moderate lockdown (National Lockdown Alert Level 4) and soft lockdown (National Lockdown Alert Level 3) scenarios.

Figure 12 shows the ARI COVID-19 SEIR model symptomatic COVID-19 cases in South Africa’s first COVID-19 epidemic wave for the no lockdown, hard lockdown (National Lockdown Alert Level 5), moderate lockdown (National Lockdown Alert Level 4) and soft lockdown (National Lockdown Alert Level 3) scenarios.

Table 14 shows the ARI COVID-19 SEIR model basic productive number, herd immunity, peak date, total infections, hospitalised cases and total deaths in South Africa’s first COVID-19 epidemic wave for the no lockdown, hard lockdown (National Lockdown Alert Level 5), moderate lockdown (National Lockdown Alert Level 4) and Soft Lockdown (National Lockdown Alert Level 3) scenarios.

Table 14 ARI COVID-19 SEIR Model Basic Reproductive Number, Herd Immunity, Peak Date, Total Infections, Hospitalised Cases and Total Deaths in the South African First COVID-19 Epidemic Wave for the No Lockdown, Hard Lockdown (National Lockdown Alert Level 5), Moderate Lockdown (National Lockdown Alert Level 4) and Soft Lockdown (National Lockdown Alert Level 3) scenarios

Figure 13 shows the ARI COVID-19 SEIR Model effective reproductive number in the South Africa’s COVID-19 first epidemic wave for the no Lockdown, hard Lockdown (National Lockdown Alert Level 5), moderate Lockdown (National Lockdown Alert Level 4) and soft Lockdown (National Lockdown Alert Level 3) scenarios.

Figure 14 shows the ARI COVID-19 SEIR Model admission status in South Africa’s first COVID-19 epidemic wave. Figure 14 shows that the ARI COVID-19 SEIR Model estimated that there would be 26 279, 5 847, 5 630, 2 947, 2 719, 1 334 COVID-19 patients in the general ward, intensive care unit, on oxygen, in high care, on the ventilator, in the isolation ward respectively in South African hospitals.

Fig. 14
figure 14

ARI COVID-19 SEIR Model Admission Status in the South African First COVID-19 Epidemic Wave

Figure 15 shows the ARI COVID-19 SEIR Model ICU Bed and Ventilator Occupied Capacity in South Africa’s first COVID-19 epidemic wave. The admission status was calculated based on the admission status means in Table 9 developed from the NICD DATCOV surveillance system data.

Fig. 15
figure 15

ARI COVID-19 SEIR Model ICU Bed and Ventilator Occupied Capacity in the South African First COVID-19 Epidemic Wave

Table 15 shows the Imperial College London COVID-19 Model (R0 = 3.3, Mitigation-Social distancing the whole population and Suppression- 1.6 deaths per 100 000 per week trigger), NCEM (Optimistic Scenario), ARI COVID-19 Model (With NPI interventions), CDDEP COVID-19 Model (Moderate Lockdown), observed total infections, active infections, total deaths, peak hospitalised cases, peak date with standard Deviation (StDev) and coefficient of variance (CoV) of South African first COVID-19 epidemic wave model outputs. The NCEM, CDDEP and ARI COVID-19 Models accurately predicted the dates of the first COVID-19 epidemic peak in South Africa. Table 15 shows that the predicted total infections, peak active infections, total deaths, and peak hospitalised cases in the reviewed models had a standard deviation of 4 865 693, 2 362 685 cases, 48 303 deaths, 25,780 cases with a coefficient of variation of 13.4%, 57.7%, 68.7% and 61.4% respectively.

Table 15 Imperial College London COVID-19 Model (Ro = 3.3, Mitigation-Social distancing the whole population and Suppression- 1.6 deaths per 100,000 per week trigger), NCEM (Optimistic Scenario), ARI COVID-19 Model (With NPI interventions), CDDEP COVID-19 Model (Moderate Lockdown), Observed Total Infections, Active Infections, Total Deaths, Peak Hospitalised Cases, Peak Date with Standard Deviation (StDev) and Co-efficient of Variation (CV) of South African first COVID-19 epidemic wave Model Outputs

Discussions

To understand the impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa, one has to investigate the non-pharmaceutical interventions (NPIs) implemented in that period, their impact on community movement, the effective SARS-CoV-2 daily contact and COVID-19 reproductive number. Also important is the understanding of the detection rate of COVID-19, observed SARS-CoV-2 lineages resulting in the COVID-19 cases, seroprevalence of SARS-CoV-2, COVID-19 vaccination and the virulence of the SARS-CoV-2 lineages observed in that period. All these factors are important in understanding an epidemic and the impact of the regressor variable.

The Impact of South African COVID-19 NPIs on Movement and the Effective SARS-CoV-2 Daily Contact Number

The following are NPIs that can be identified from South Africa’s COVID-19 policy response implemented through the National Lockdown Alert Levels during the first COVID-19 epidemic wave:

  • Entry and exit screening at borders.

  • Limitations of movements in the form of national, provincial, and district lockdowns and curfews.

  • Ban/limitation of mass gatherings.

  • Closure/Limitations of institution and business activities which included the closure of entertainment establishments, schools, higher tertiary institutions, and non-essential services.

  • Ban/limiting alcohol and tobacco industries, later banning/limiting liquor licence operating hours.

  • Isolation, quarantine of potentially infected persons and contact tracing protocols through testing programmes.

  • Use of PPE for healthcare workers (high type variation including isolation PPE), essential services (moderate type variation) and the general population (low type variation in general masks).

  • Hygienic protocols include social distancing, widespread use of sanitiser and frequent hand washing.

The COVID-19 NPIs implemented by the South African government were similar to those implemented globally in the Influenza (H1N1) pandemic of 1918 [26]. They show a focus on restricting contact between individuals within the population. The ban/limiting of the alcohol and tobacco industries was meant to reduce the pressure in trauma wards (by reducing the incidence of accidents reported to these wards), particularly car accident cases and also to improve general social behaviour adherence to NPIs [68].

In 2017, South Africa had 61.8% of households with at least one member who had access to or used the Internet [69]. As of 2020, there were 36.54 million internet users, 22 million social media users and 103.5 million mobile connections in South Africa [70]. The high penetration of the internet in South Africa shows the potential of using information gathered from the internet in understanding the South African community as done by the Google Community Mobility reports. The spike in the change from baseline in movement in the South African grocery and pharmacy locations observed in the Google Community Mobility reports (Fig. 3) 1 day prior and a day in the implementation of the first National Lockdown Alert Level 5 indicates sudden increased movement in these locations. This can be attributed to panic buying of groceries and medication by South Africans which was observed due to anticipation of the COVID-19 pandemic and the lockdown implementation [71, 72]. The high modulus change from baseline (33–78%) in movement in South African locations during the National Lockdown Alert Level 5 suggests that the National Lockdown Alert Level 5 was effective in reducing the movement of communities in South African locations. The National Lockdown Alert Level 4 had a lower modulus change from baseline in movement in South African locations compared to the National Lockdown Alert Level 5 (39–62%). This is due to exceptions of walking, running, and cycling and the introduction of a curfew system in the National Lockdown Alert Level policies. This result also reflects the impact on movement due to the relaxed policies in the National Lockdown Alert Level 4 from the Alert Level 5. Similar results were observed in modulus change from baseline in movement in South African locations in the National Lockdown Alert Level 3 compared to the National Lockdown Alert Level 4. This was due to relaxed policies such as permitting all businesses to operate under strict hygienic protocols, allowance of interprovincial travel and a decreased curfew period in the National Lockdown Alert Level 3 from Alert Level 4. The grocery and pharmacy and workplaces locations were the most impacted. Results shown in Fig. 3 show that the National Lockdown Alert Levels 1 and 2 had a similar impact on the movement in the South African communities. The impact of the National Lockdown Alert Level 3 on movement in South Africa was 32 ± 9% more than that in Alert Level 2 for all locations studied. Similar results were observed between the National Lockdowns Alert Levels 5 and 4 and 4 with 3.

The effective SARS-CoV-2 daily contact numbers (β) in South Africa obtained from the ARI COVID-19 SEIR model were 0.498, 0144, 0.196, and 0.208 day−1 for the no lockdown, National Lockdown Alert Level 5, 4 and 3 model scenarios respectively (Table 5). These results translate into a reduction of 71.1%, 60.6%, and 58.1% in the effective daily contact number from having no lockdown in South Africa to the implementation of the National Lockdown Alert Levels 5, 4 and 3 respectively. The difference in the effective daily contact number between the National Lockdown Alert Levels 5 and 4 was -36.1% while that between Alert Levels 4 and 3 was -6.12%. The results from the South African Google Community Mobility Report and the estimated effective SARS-CoV-2 daily contact number (β) in South Africa during the first COVID-19 epidemic wave suggests that the difference in movements in all locations studied between the National Lockdown Alert Levels implemented which was approximately 31% to 36% had a 6.12% to 36.1% impact on the effective SARS-CoV-2 daily contact number. The results obtained in this study suggest that the National Lockdown Alert Level 3 was as effective as the Alert Level 4 in reducing the effective SARS-CoV-2 daily contact number in South Africa.

COVID-19 detection in the first COVID-19 epidemic wave in South Africa

Throughout the COVID-19 pandemic and particularly in the first COVID-19 epidemic wave, COVID-19 testing was an important tool in the isolation, quarantine of potentially infected persons and contact tracing protocols in South Africa. COVID-19 tests can be classed into two categories either viral (Genome sequencing/reverse transcriptase PCR (rRT-PCR/ antigen) or serological (antibody) [73]. Viral tests can detect the genetic material of the virus and thus can determine if a person is currently infected with SARS-CoV-2. Samples or specimens for testing are usually taken through nasopharyngeal and oropharyngeal swabs (upper respiratory specimens) and sputum, endotracheal aspirate, and bronchoalveolar lavage (lower respiratory specimens). Specimens must be swiftly transferred to laboratories, stored and shipped between 2 °C to 8 °C or they may be frozen at -20 °C with recommendations for freezing at -70 °C. A viral test for SARS-CoV-2 in the specimen is then conducted in laboratories through real-time reverse transcriptase-polymerase chain reactions (rRT-PCR). The COVID-19 rRT-PCR is a nucleic acid amplification test (NAAT) [74]. A positive COVID-19 rRT-PCR indicates that the specimen collected has SARS-CoV-2 thus the person from which the specimen is collected has a SARS-CoV-2 infection. It must be noted a negative rRT-PCR does not rule out the possibility of a SARS-CoV-2 infection. Negative tests can also be caused by poor quality specimens, cross-contamination, specimens collected too early or late into the infection, specimens not handled appropriately and technical limitations such as viral mutation and PCR inhibition [74]. A positive COVID-19 rRT-PCR is considered accurate and usually not repeated. The time from sampling to result in a report for this test can take from less than 24 h to up to a week depending on the laboratory testing demand and resources.

Serological tests detect antibodies in the blood generated by the immune response to an infection. They include a lateral-flow antibody, bead-based, enzyme-linked immunosorbent assays, and automated serology platforms. These essays assess the presence of Immunoglobulin M (IgM) and Immunoglobulin G (IgG). Antibodies can take up to 1 to 3 weeks to develop after infection and may stay in the blood for several days after recovery [9]. However, in acute infections, there is a potential waning of the antibodies post-infection [75]. IgM develops in the innate phase of the immune response and IgG in the later stages of the infection [9]. For COVID-19, the development of IgM has been observed to occur 5 to 7 days after the onset of symptoms and IgG, 10 to 14 days after symptom onset [75]. With the incubation period of COVID-19 being between 4 to 5 days [5], the use of serological testing is not recommended in this period [75]. Specimens for the COVID-19 serological test are obtained through a finger stick (using a bloodletting set) or blood draw. Results can be obtained from less than 24 h to 1 to 3 days after the test. COVID-19 serological tests have a limitation in sensitivity and specificity with the sensitivity of the tests ranging from 33.3% to 65.5% [75]. A positive COVID-19 serological test usually requires repetition for confirmation. A negative COVID-19 serological test does not exclude past or current infection due to potential waning or low levels of antibodies [75]. The National Health Laboratory Service (NHLS) and National Institute for Communicable Diseases (NICD) were the national laboratories conducting the COVID-19 testing in South Africa and for other Southern African countries such as Lesotho, Namibia and Eswatini in their earlier COVID-19 epidemics. Major private laboratories involved in COVID-19 testing in South Africa included Abbott, Ampath, Pathcare and Lancet Laboratories [76].

Laboratory testing in South Africa was conducted for persons under investigation (PUI) which included community screening and testing programmes that were initiated in April 2020 and discontinued in the week of 17th of May 2020. Testing was performed using rRT-PCR and laboratories used in-house and/or commercial PCR assays to conduct testing for the presence of SARS-CoV2 RNA [65]. The difference in the cumulative COVID-19 tests shown in Table 6 and those reported by the NICD, 2020d can be attributed to (i) difference in sources reporting, (ii) cumulative COVID-19 tests in shown Table 6 including serological tests. According to the NICD, South African public and private sector laboratories conducted 45.9% and 54.1% of the cumulative COVID-19 tests respectively in the period reported from 2020/03/01 to 2020/10/03. It must be noted that the COVID-19 Positive cases to Testing ratio particularly if the majority of the testing is through rRT-PCR are not an indicator of the seroprevalence in the population. According to an NICD report, the seroprevalence in the Cape Town metropolitan sub-districts (Western Cape Province) after the peak of the first epidemic infections was 39% [77].

COVID-19 testing was limited and challenging in South Africa in the initial stages of the COVID-19 pandemic. This was due to the limited supply and global competition for the resources to perform COVID-19 testing such as reagents, equipment and assays [78]. COVID-19 testing increased up to 57 000 tests per day in South Africa in the period 2020/03/13 to 2020/07/17. The correlation between COVID-19 testing and cases shows that testing has an impact on how the epidemic is observed/reported. Increasing testing increases the accuracy of case reporting however this is limited by the testing approach. Random testing can aid in increasing the accuracy of the viro-prevalence and seroprevalence of COVID-19. However, most COVID-19 testing in South Africa has been targeted (non-random or systematic) which includes contact tracing efforts [65]. Another limitation in reported COVID-19 cases was that asymptomatic COVID-19 cases were difficult to identify in the population due to a lack of symptoms. Studies have shown a high proportion of asymptomatic COVID-19 cases in COVID-19 reported cases [49,50,51]. The result is that there is a probability that some COVID-19 cases in South Africa were not reported.

SARS-CoV-2 lineages detected in the first COVID-19 epidemic wave in South Africa

According to the Network for Genomics Surveillance in South Africa (NGS-SA), at least 101 introductions of SARS-CoV-2 were estimated in South Africa, with the bulk of the important introductions occurring before the lockdown from Europe. South African genomes in the period of 2019/12/24–2020/08/26 were assigned to 42 different lineages with 16 South African-specific lineages. The largest monophyletic linear clusters that spread in South Africa during the lockdown and then grew into large transmission clusters during the peak of infections during the first COVID-19 epidemic wave were the C.1, B.1.1.54, B.1.1.56 lineage clusters. These main lineages accounted for 42% of all sampled South African sequences (1365 South African genomes). Genomes belonging to these lineages were sampled in five provinces in South Africa (North-West, Limpopo, KwaZulu-Natal, Gauteng and Free State) [79]. Spatiotemporal phylogeographic analysis suggests that the variant of concern, SARS-CoV-2 501 Y.V2 lineage (B.1.351) emerged in early August after the peak and in the period of the negative exponential phase of the first COVID-19 epidemic wave in South Africa [80]. These results suggest that the C.1, B.1.1.54, and B.1.1.56 lineage clusters were major drives of the first COVID-19 epidemic wave in South Africa.

The impact of South African COVID-19 NPIs on the initial COVID-19 reproductive number, cases and deaths in the first COVID-19 epidemic wave in South Africa

The cumulative reported COVID-19 cases, recovered cases and deaths in South Africa in the first COVID-19 epidemic wave period were 676 084, 609 584 and 16 866 respectively (Fig. 5). 90.2% of the COVID-19 cases reported in the respective reported period recovered. The total peak number of COVID-19 active cases in South Africa’s first COVID-19 epidemic wave was 173 587 COVID-19 cases (Table 7). The results in Fig. 5 show that the National Lockdowns Alert Levels 5 and 4 were implemented at the start of the epidemic however the COVID-19 policy in South Africa was then eased to Lockdown Alert Level 3 (2020/06/01–2020/08/17) where the majority of the positive exponential phase of the first epidemic wave was observed. The COVID-19 policy was further eased to the National Lockdown Alert Levels 2 and 1 in the negative exponential phase of the first epidemic wave. The first COVID-19 epidemic wave in South Africa lasted for 205 days from the first reported case. Gauteng, KwaZulu Natal, Eastern Cape, and Western Cape provinces had 26.0%, 19.3%, 11.3%, and 11.8% of the total first-peak COVID-19 active cases respectively (Table 7). This represents 68.4% of the total peak COVID-19 active cases observed in South Africa’s first COVID-19 epidemic wave. The observed first COVID-19 epidemic wave in South African provinces had different amplitudes and periods. Epidemiologically this result can be explained by the district and provincial confinement of the South African population due to the National Lockdown Alert Levels, the difference in testing capacity, population, population distribution, residential settings and business activities in the provinces. The provincial testing capacity may have affected the reporting of cases while the latter may have affected the contact rates in the provincial population. The Western Cape province was the first province to observe peak active cases on the 10th of July 2020. While the Northern Cape province was the last province to observe a peak in active cases on the 5th of September 2020. The South African national average date of peak active cases in the first COVID-19 epidemic wave was on the 26th of July 2020.

The results from the ARI COVID-19 SEIR model show that if no COVID-19 NPI policies were implemented in South Africa, 25 391 522 COVID-19 active cases would have occurred at the peak of South Africa’s first COVID-19 epidemic wave (Fig. 11). This corresponds to almost 42.6% of the South African population. If the National Lockdown Alert Level 5 policy had been continued for the duration of the South African first COVID-19 epidemic wave, the peak active COVID-19 cases would have been reduced to 2 028 381 cases (Fig. 11). While if the National Lockdown Alert Level 4 policy had been continued 4 621 066 peak active COVID-19 cases would have occurred. The results from the ARI COVID-19 SEIR model also show that the impact of the adjustment of NPI policies in South Africa up to the National Lockdown Alert Level 3 resulted in the peak active COVID-19 cases in South Africa being reduced to 8 057 754 cases. This result indicates that the COVID-19 NPI policies implemented by the South African government in the form of national lockdown alert levels played a significant role in the reduction of active COVID-19 cases in South Africa.

Symptomatic COVID-19 cases are infectious individuals within the population of the model with either mild, moderate, severe or critical symptoms. Symptomatic COVID-19 cases have a high probability of being identified due to the awareness and visibility of COVID-19 symptoms or individuals seeking treatment. The results from the ARI COVID-19 SEIR model show that if no COVID-19 NPI policies were implemented in South Africa, 1 964 568 symptomatic COVID-19 cases would have occurred at the peak of South Africa’s first COVID-19 epidemic wave (Fig. 12). This value represents 7.74% of the active COVID-19 cases. Implementation of the National Lockdown Alert Level 5 policy during the first COVID-19 epidemic wave in South Africa would have resulted in the symptomatic cases being reduced to 123 359 cases. While the National Lockdown Alert Level 4 would have resulted in the symptomatic cases being reduced to 280 325 cases. The impact of the adjustment of NPI policies in South Africa up to the National Lockdown Alert Level 3 resulted in the peak symptomatic COVID-19 cases in South Africa being reduced to 506 402 cases. The peak number of reported active COVID-19 cases in South Africa’s first COVID-19 epidemic wave was 173 587 (Fig. 5). The lower peak active COVID-19 cases reported relative to that in the ARI COVID-19 SEIR model indicates that a large number of symptomatic cases were not reported. The model symptomatic COVID-19 cases were 2.91 times more than the reported peak active COVID-19 cases.

The results from the ARI COVID-19 SEIR model show that if no COVID-19 NPI policies were implemented in South Africa, the initial basic reproductive number would have been 4.73 (Table 14). The implementation of the National Lockdown Alert Level 5 policy resulted in a decrease in the initial reproductive number by 71% to 1.37. The decrease in the initial reproductive number can be attributed to the decrease in the daily effective SARS-COV-2 contact number due to the NPI policy. If the National Lockdown Alert Level 5 policy was implemented for the duration of South Africa’s first COVID-19 epidemic wave, the peak total COVID-19 infections would have been reduced by 91.8% to 2 074 379 cases. The peak of the first epidemic wave would have been delayed by 147 days to the 1st of October 2020. Implementation of the National Lockdown Alert Level 4 resulted in an initial reproductive number of 1.87. If the National Lockdown Alert Level 4 policy was implemented for the duration of South Africa’s first COVID-19 epidemic wave, the peak total COVID-19 infections would have been reduced by 73.1% to 6 836 279 cases. The peak of the first epidemic wave would have been delayed by 79 days to the 25th of July 2020. Implementation of the National Lockdown Alert Level 3 resulted in an initial reproductive number of 1.98. The adjustment to the National Lockdown Alert Level 3 policy resulted in a reduction in the peak total COVID-19 infections by 68.3% to 8 060 344 cases. The peak of the first epidemic wave was delayed by 84 days to the 30th of July 2020. The results from the ARI COVID-19 SEIR model also show that if no COVID-19 NPI policies were implemented in South Africa, the COVID-19 herd immunity required in South Africa would be 79% (Table 14). The implementation of NPI policies results in a decrease in the required herd immunity with the condition that the NPI policy is maintained. The results in Fig. 13 shows that for the implemented NPI policies in South Africa up to the National Lockdown Alert Level 3, the effective reproductive number was between 1.98 to 0.40 in the first COVID epidemic wave in South Africa. According to the NICD, the nationally average reproductive number during the period of the National Lockdown Alert Level 5 was 1.29 (95%CI: 1.58–1.96) and rose to 1.5 by the end of April. While the average reproductive number in National Lockdown Alert 3 was 1.05 (95%CI:1.01–1.09) between 1 June and 1 August and dropped below 1 during the last week of July [81]. These results are similar to what was obtained by the ARI COVID-19 SEIR Model as shown in Fig. 13.

The impact of South African COVID-19 NPIs on COVID-19 hospitalised cases and deaths in the first COVID-19 epidemic wave in South Africa

Most COVID-19 patients admitted in South African hospitals during the first COVID-19 epidemic wave were admitted to the general ward (Fig. 7). At the peak of the first COVID-19 epidemic wave, there was a total of 8 319 COVID-19 patients in South African hospitals with 5 745 (general ward), 1 520 (intensive care unit), 989 (on oxygen), 799 (on ventilators), 763 (high care) and 442 (isolation ward) respectively. Although the severity of COVID-19 in South Africa cannot be conclusively drawn from hospital admissions, the result of the trend observed in the COVID-19 admission status in this study corresponds with the severity of COVID-19 described in [12, 82]. The mean COVID-19 patient discharge rate in the first COVID-19 epidemic wave in South Africa was 11.9 days per patient (Table 8). The mean COVID-19 patient case fatality rate (CFR) in hospital and outside the hospital was 2.06%, 95% CI [1.86–2.25] (deaths per admitted patients) and 2.30%, 95% CI [1.12–3.83] (deaths per severe and critical cases) respectively. The COVID-19 CFR outside the hospital was observed to be higher than in the hospital. The constant positive gradient between the cumulative COVID-19 deaths and discharged patients data (shown in Fig. 8) indicates a constant CFR and discharge rate in the respective period. The constant daily hospital CFR and discharge rate in South African hospitals indicate good clinical management in the face of adversity where the increasing number of cases towards the peak of the first epidemic wave did not decrease and increase the hospital COVID-19 discharge and death rate respectively. COVID-19 cases in South African hospitals were largely managed using the WHO “Clinical management of COVID-19: interim guidance, 27 May 2020” which was updated throughout the COVID-19 pandemic [12]. Pharmaceutical interventions such as treatment of COVID-19 patients with medication and COVID-19 vaccination were not investigated in this study. There were no reported COVID-19 vaccinations in South Africa in the first COVID-19 epidemic wave according to the Department of Health Republic of South Africa [83]. Treatment of COVID-19 patients with medication could have played a role in the management of the severity of COVID-19 in hospitalised cases and thus forms a limitation to this study.

The mean COVID-19 admission status in South African hospitals was 58.5%, 95% CI [58.1–59.0] in the general ward, 13.4%, 95% CI [13.1–13.7] in the intensive care unit, 13.3%, 95% CI [12.6–14.0] on oxygen, 6.37%, 95% CI [6.23–6.51] in high care, 6.29%, 95% CI [6.02–6.55] on ventilator and 2.13%, 95% CI [1.87–2.43] in isolation ward respectively (Table 9). These results suggest that most COVID-19 patients reporting to South African hospitals were admitted into the general wards. The proportion reporting to intensive care units and on oxygen was similar regarding confidence intervals. A relatively low proportion of patients were admitted to the isolation ward. Children in the age groups of 0 to 9 years and 10 to 19 years made up 2.32%, 95% CI [2.21–2.4] and 1.75%, 95% CI [1.71–2.4] of the COVID-19 hospitalised cases in South African hospitals respectively (Table 10). This was relatively lower than other age groups reported in South African hospitals indicating low case incidents in the severe and critical COVID-19 disease in children. According to WHO, the COVID-19 disease in children is relatively rare with a small proportion of individuals under 19 developing severe or critical symptoms [5]. In the case of South Africa, this was true and this phenomenon was also noted by the NICD [84]. People in the age groups of 40 to 49 years and 50 to 59 years made up 20.4%, 95% CI [19.9–20.9] and 25.3%, 95% CI [24.5–26.0] of the COVID-19 hospitalised cases in South African hospitals respectively. People in the age groups over 40 years accounted for 78.9% of the COVID-19 hospitalised cases in South African hospitals. People in the age groups of 20 to 29 years and 30 to 39 years made up 8.04%, 95% CI [7.65–8.44] and 18.1%, 95% CI [17.5–18.7] of the COVID-19 hospitalised cases in South African hospitals respectively.

The results from the ARI COVID-19 SEIR model show that if no COVID-19 NPI policies were implemented in South Africa, the estimated peak number of hospitalised cases would have been 100 653. The implementation of the National Lockdown Alert Level 5 policy would have resulted in the COVID-19 hospitalised cases being reduced by 89% to 10 574 cases and total COVID-19 deaths by 67% to 26 509 deaths (Table 14). While peak COVID-19 hospitalised cases would have been reduced by 69% to 31 003 cases and total COVID-19 deaths to 61 140 deaths. The adjustment to the National Lockdown Alert Level 3 policy resulted in peak COVID-19 hospitalised cases being reduced by 69% to 31 003 cases. The discrepancy between the peak COVID-19 hospital cases obtained in the ARI COVID-19 SEIR model and those reported is due to two major factors i) COVID-19 hospital cases were underreported during the first COVID-19 epidemic wave. There was a lag between the establishment of the NICD DATCOV surveillance system and the enrollment to reporting to this system by South African hospitals. This can be seen by the increase in number of hospitals reporting to this system over this period. Initially, 204 Facilities were reporting, and this increased to 434 Facilities by 4 September 2020. By the end of the COVID-19 pandemic, 666 Facilities were reporting to the NICD DATCOV surveillance system [44]. ii) The ARI COVID-19 SEIR model predicted a larger number of COVID-19 cases than reported due to accounting for the entire South African population (South African population taken as the sample size) and the excess deaths observed in South Africa. The application of the hospitalisation rate to the contact rates in this sample size will naturally lead to a larger number of hospitalised cases as opposed to the observed sample size from the reported hospitalised cases.

COVID-19 deaths in children in South African hospitals were relatively low with age groups 0 to 9 years and 10 to 19 years making up 0.21%, 95% CI [0.19–0.2] and 0.28%, 95% CI [0.27–0.4] of the COVID-19 deaths in South African hospitals respectively (Table 11). People in the age groups of 50 to 59 years and 60 to 69 years had the highest proportion of COVID-19 deaths in South African hospitals. Both respective age groups made up 24.3%, 95% CI [23.9–24.6] and 26.0%, 95% CI [25.8–26.3] of the COVID-19 deaths in South African hospitals. The proportion of COVID-19 deaths and risk of COVID-19 deaths in South African hospitals increased with an increase in age groups (Table 12). People in the age groups over 80 years had the highest risk of dying from COVID-19 in South African hospitals with a cumulative COVID-19 death risk ratio of 23.7, 95% CI [22.6–25.1] times more than the age group 0 to 9 years. The risk of dying from COVID-19 in South African hospitals for age groups over 20 years approximately doubled with an increase in age of 10 years. A confounding factor in COVID-19 deaths in South African hospitals was disease comorbidities. In the period of 5 March to 18 July 2020, in Western Cape, South Africa COVID-19 comorbidity with Diabetes was reported in most hospitalized cases followed by HIV then Hypertension at 38.5%, 37.4%, and 36.4% respectively. While, chronic kidney, pulmonary, and tuberculosis (TB) were reported in 6.8%, 12.3%, and 11.8% of the hospitalized cases in the Western Cape province respectively. COVID-19 comorbidity with diabetes was reported in most reported deaths in Western Cape, South Africa followed by Hypertension at 55.1% and 47.2% respectively. While, HIV, Chronic Kidney disease, Asthma, and TB were reported in 16.2%, 14.8%, 11.5%, and 3.2% of the reported deaths in the Western Cape province respectively [85].

The weekly excess natural and COVID-19-reported deaths in the first COVID-19 epidemic wave in South Africa were characterised by positive exponential growth in the period of 2020/03/15 to 2020/07/26 and negative exponential decline thereafter (Fig. 9). The peak of weekly excess natural and COVID-19-reported deaths observed on the 26th of July 2020 in Fig. 9 in the first COVID-19 epidemic wave in South Africa coincided with the peak of active COVID-19 cases. The estimated peak date for hospital cases in South Africa’s first COVID-19 epidemic wave by the ARI COVID-19 SEIR Model was the 6th of August 2020. The peak of weekly excess natural and COVID-19 reported deaths in South Africa’s first COVID-19 epidemic wave was 6676 and 2057 deaths respectively. The weekly excess (natural) deaths, excess (natural) to natural deaths (%), and excess deaths (natural) to COVID-19 death ratio was 2114, 95% CI [1239–2990], 16.7%, 95% CI [10.9–22.5] and 1.12, 95% CI [0.55–1.68] respectively (Table 13). The relatively low value of the excess (natural) to natural deaths in South Africa shows that the COVID-19 disease or epidemic did not account for the majority of the natural deaths occurring in South Africa during the first COVID-19 epidemic wave. This is reflective of the high disease burden in South Africa. The estimated crude death rate in South Africa in 2020 (calculated in 2019) was 9.5 per 1000 of the population [86]. In 2016, non-communicable diseases (NCD) in South Africa accounted for 51% of the total deaths in South Africa [87]. The results in Fig. 10 indicate that COVID deaths were under-reported during the epidemic wave with the accuracy decreasing in the positive exponential phase of the epidemic wave. The results from the ARI COVID-19 SEIR model show that if no COVID-19 NPI policies were implemented in South Africa, there would have been a total of 79 631 COVID-19 deaths in the first COVID-19 epidemic wave in South Africa. The total COVID-19 deaths estimated by the ARI COVID-19 SEIR model for the no-national lockdown scenario is a conservative estimate. This estimate is based on the upper confidence intervals of the CFR shown in Table 8 which were derived from periods in which COVID-19 NPI policies were implemented. The impact of the higher number of active COVID-19 cases in the no-lockdown scenario would have had an impact on the CFR. The adjustment to the National Lockdown Alert Level 3 policy resulted in the reduction of the total COVID-19 deaths to 64 640 deaths.

According to [88] there were 3 200 ventilators and 3 300 ICU beds in South Africa by May 2020. Based on these estimates of the available ventilators and ICU beds in South Africa, the estimated date the ICU occupied capacity for COVID-19 hospitalised cases in South Africa was breached was the 17th of July 2020 with the occupied capacity at the peak at 167% as shown in Fig. 15. While the ventilator capacity for COVID-19 hospitalised cases was estimated not to be breached during the first COVID-19 epidemic waves in South Africa. The estimated peak occupied ventilator capacity for COVID-19 hospitalised cases was 77%. Indicating that South Africa had sufficient ventilators and insufficient ICU beds in the first COVID-19 epidemic wave (Fig. 15). The results obtained in this section indicate some level of preparedness by the South African healthcare system for the first COVID-19 epidemic wave. However, the distribution and management of these resources is an important factor that needs to be assessed to develop adequate conclusions regarding the preparedness of the South African healthcare system in the first COVID-19 epidemic wave.

COVID-19 modelling of NPIs in the first COVID-19 epidemic wave in South Africa

COVID-19 has been widely modelled with variations of the SEIR model [29,30,31, 33,34,35, 89]. In this discussion, we explore COVID-19 models which had a significant influence on South Africa’s policy response to COVID-19 and the ARI COVID-19 Model. We also explore the models’ limitations and success.

One of the earliest COVID-19 transmission models to be published was the Imperial College London COVID-19 Model [31, 36]. The Imperial College London COVID-19 Model had a great influence on the early policy response to COVID-19 in many countries including countries in Africa [31]. The Imperial College London Model explored the use of Non-Pharmaceutical Interventions (NPI) in suppressing or mitigating COVID-19 using a mathematical transmission model. Ethical and economic factors were not explored in this model. The NPIs considered in this model were home isolation and quarantine, social distancing and closure of schools and universities. Interventions were modelled to reduce the effective contact rates thereby reducing the transmission of COVID-19. The transmission was explored in households, workplaces, schools, or random communities. Mitigation strategies explored were the reduction of COVID-19 Infections and protection of high-risk groups from exposure to COVID-19 whilst suppression explored the reduction of the Basic Reproductive Number (R0) to less than the critical disease-free equilibrium point (less than 1). The model estimated that NPIs if implemented would result in a reduction in Health Care COVID-19 cases by two thirds and COVID-19 deaths by half. Whilst without interventions critical care beds would be exceeded over 30 times compared to capacity (in Great Britain and the United States of America). The NPIs would have to be maintained until the availability of a vaccine to immunise the population. If NPIs were not maintained, it was suggested that a potential rebound of transmission could occur with an epidemic comparable scale to that of no interventions. Population-wide social distancing was observed to have the largest impact in suppressing COVID-19 whilst stopping mass gathering was predicted to have little impact because of the short contact time relative to household settings. The model explored pre-symptomatic infectiousness (12 h prior symptoms), assumed that two-thirds of cases are symptomatic, 30% of hospitalised cases will require critical care whilst 50% of critical care cases will die [31]. In retrospect, the Imperial College London COVID-19 model did well to quantify the magnitude of the impact of NPIs in COVID-19 mitigation. The prediction of “Second Waves” of the COVID-19 pandemic after the relaxation/lifting of some of the NPIs particularly movement restrictions were observed in Europe (August /September 2020) [90] and in Africa (November/December 2020) [91]. Although the initial Imperial College London COVID-19 model was successful in understanding the impact of NPIs on the COVID-19 pandemic, it overestimated the severity of COVID-19 [92] and was subsequently revised [93]. Asymptomatic cases of COVID-19 have been observed to account for more than 33% [49,50,51]. Also, in retrospect, in adapting such a model to Africa’s policy response, the model did not consider the risk factor of disease comorbidity to COVID-19 severity as data from China was used to estimate parameters, particularly in Africa where there is a high disease burden. The model did not account for potential cases which are not hospitalised and the impact of the COVID-19 pandemic on excess natural deaths in Africa.

Another COVID-19 Model of note was the model produced by One Health Trust formerly the Center for Disease Dynamics, Economics & Policy (CDDEP) [30, 32]. The CDDEP COVID-19 Models tried to understand the impact of Country-Wise Lockdowns [32] and the Health Care system preparedness of African countries [30]. The CDDEP COVID-19 Model had a more revised severity of COVID-19, particularly in the proportion of asymptomatic cases and the severe case fatality rate relative to the Imperial College London COVID-19 Model [32]. The CDDEP COVID-19 Model also attempted to account for the rate progression of COVID-19 due to Age, TB, and HIV/AIDS. The CDDEP COVID-19 Model predicted that 31 of 50 African countries will not have enough hospital beds and even if 30% of severely infected patients seek health services only 34 of 48 African countries have enough ICU Beds. Only five countries (Carbo Verde, Gabon, Egypt, and South Africa) would have enough ventilators. The CDDEP COVID-19 Model predicted the delay in peak due to lockdown measures and that implementation of large-scale mitigation measures may not be feasible or sustainable in Low and Middle-Income Countries (LMICs) in Africa [30]. The influence of COVID-19 Modelling on Southern Africa’s policy response to COVID-19 remains under-reported and there are limited published National COVID-19 Models except South Africa. The Africa Center for Disease Control (Africa CDC) in response to the COVID-19 pandemic created a COVID-19 Modelling group in a bid to try to foster collaboration and sharing of information within COVID-19 modellers in Africa.

South Africa received much attention concerning COVID-19 Modelling with several models being published and noted by the South African government [37]. Of note, are the National COVID-19 Epi Model (NCEM) and the National COVID-19 Cost Model (NCCM) by the South African COVID-19 Modelling Consortium, 2020. The NCEM is an SEIR stochastic compartmental transmission model that was developed to estimate the total and reported incidence of COVID-19 cases in South Africa up to November 2020. While the NCCM was a model developed to determine the COVID-19 response budget in South Africa. The NCEM and NCCM played a key role in South Africa’s policy and planning response to COVID-19. The NCEM assumed a relatively high proportion of asymptomatic cases (75%) and symptomatic cases (95%) and modelled an optimistic and pessimistic scenario. In the optimistic scenario, a Hard lockdown measure reduced COVID-19 transmissions by 60%, Moderate Lockdown by 35% and social distancing by 20%. In the pessimistic scenario, a Hard lockdown measure reduced COVID-19 transmissions by 40%, Moderate Lockdown by 25% and social distancing by 10%. The NCEM anticipated that lockdowns would flatten the epidemic curve and delay the COVID-19 peak in South Africa by 2 to 3 months. South Africa would observe peak demand for hospital care between August and September 2020. These factors were dependent on the response of the population’s social behaviour to measures. The NCCM estimated a total budget of 26 to 32 Billion Rands would be required for the COVID-19 response in South Africa. The budget would cover Personal Protective Equipment (PPE), additional ICU, hospital beds and staff, additional PHC staff, ventilators, drugs, isolation facilities, testing and surveillance and port health budgets. The NCEM did not account for disease risk factors and location transmission risks but rather assumed random mixing at provincial levels. For age-related risks, the NCEM used population-adjusted age-specific mortalities from the Chinese epidemic. The NCEM model did well in predicting the COVID-19 epidemic in South Africa. Particularly the expected peak (magnitude and progression). The NCEM took account and highlighted the impact of the COVID-19 epidemic at a provincial level with provincial variability noted in the difference in seeding and community contact behaviour. The NCEM also constantly revised its parameters ensuring more accurate modelling as the COVID-19 Epidemic in South Africa progressed [94].

Most COVID-19 Models were proactive in attempting to predict and quantify the epidemic in Africa to advise on Africa’s early policy response to the epidemic. They largely used age-disease deterministic modelling using COVID-19 clinical data from the earlier COVID-19 epidemic in China. The ARI COVID-19 SEIR Model can be considered a semi-reactive model. The ARI COVID-19 SEIR Model was developed well within the epidemic in South Africa (July 2020). The model used regression and sensitivity analysis of South African COVID-19 reported cases (before lockdown measures), COVID-19 deaths and excess natural deaths (during lockdown measures) to quantify the impact of implemented NPIs in the suppression of COVID-19 in South Africa. This was done by adjusting the effective SARS-CoV-2 daily contact number during the regression analysis at the different National Lockdown Alert Levels (5, 4, 3) implemented in South Africa and seeding the model with observed COVID-19 Deaths (accounting for Excess Natural Deaths). The model also used regression of South African as opposed to Chinese COVID-19 epidemiological data to obtain estimates of model parameters.

The coefficient of variation of outputs from the discussed COVID-19 models were 13.4% (Predicted Total Infections), 57.7% (Predicted Peak Active Infections), 68.7% (Predicted Total Deaths) and 32.0% (Predicted Total Deaths -Excluding the Imperial College London COVID-19 Model), 61.4% (Predicted Peak Hospitalised Cases) and 0.0021% (Peak Date) respectively (Table 14). The relatively low coefficient of variance in model-predicated total infections and peak date implies that the COVID-19 models had similar predictions of the total progression in COVID-19 transmissions in the first COVID-19 epidemic wave in South Africa. The relatively high coefficient of variance in the model predicted COVID-19 peak active infection, hospitalized cases and total deaths implies that the COVID-19 models had similar predictions of the total progression in COVID-19 transmissions in the first COVID-19 epidemic wave in South Africa shows the sensitivity in the model parameters used in COVID-19 modelling considering different model parameters and values were used in the reviewed models. This is particularly reflective of the within transmission parameters such as the proportionality of severity of COVID-19, recovery and death rates. The relatively high coefficient of variance also shows the uncertainty in the accuracy of the reviewed COVID-19 models in predicting the severity of COVID-19 however the COVID-19 models were accurate in predicting the progression of the first COVID-19 epidemic wave in South Africa.

From the COVID-19 models discussed, the predicted peak of active cases was more than 27 to 46 times than the observed/reported. This observation highlights the need for more rigorous testing in South Africa especially with most COVID-19 cases estimated to be asymptomatic. Improvement in the testing protocol (inclusion of serological testing) is also needed to avoid false positives. A case in point in this argument is the notion that the epidemic in South Africa did not progress to the extent the COVID-19 models predicted. Factors to consider in this argument are the following: i) COVID-19 Models conducted scenario analysis for the duration of the entire epidemic. Therefore, changes in NPIs during the epidemic caused a difference between the model and observed results. The ARI COVID-19 Model as a semi-reactive model tried to account for changes in the NPIs used by Southern African governments and still obtained results that correlate with the pro-active models. Therefore, this point may not be valid in the argument. ii) COVID-19 Models assumed homogenous or random mixing. All models made this assumption. With a note of the NCEM which attempted to understand seeding and contact rates at a provincial level however still assuming random mixing in provinces. The COVID-19 Epidemic in South Africa seems to be occurring in pockets within the population as clusters of cases [95]. South Africa has a high rural population (low density) with the urban population agglomerated in slums (high density). With the epidemic in most countries seeding in agglomerated cities, the rate of contact from high-density to low-density areas in the presence of lockdowns influenced the rate of transmission. Clustering of the cases within the population suggests that populations are not homogenously mixing as assumed especially in the presence of NPIs. This could mean models were overestimating contact rates and the progression (magnitude) of the epidemic.

The COVID-19 models showed that implementation of NPIs results in the lowering of the required herd immunity to reach the Disease-Free Equilibrium. Therefore, once NPIs particularly movement restrictions/lockdowns are lifted there is likely to be a secondary wave, infecting the susceptible from the primary wave. COVID-19 models have been depicting the epidemic as a single occurrence, the implementation/relaxation/removal of NPIs can result in negative or positive damping of the epidemic curve resulting in the epidemic occurring in a series of waves as opposed to a single occurrence.

Challenges faced during the implementation of COVID-19 NPIs in South Africa

Several factors contributed to the preparedness of South Africa’s population to follow the COVID-19 policies implemented by the South African government. These factors include socio-economic status, age, education, and whether or not families care for vulnerable individuals like children or the elderly [96]. People who lived in informal dwelling settlements found it particularly difficult to isolate adequately during the National lockdown Alerts Level 5 and 4 when movement restrictions were strict. Due to South Africa’s history of racial segregation as well as apartheid, other race groups were more prepared to self-isolate compared to the Black population. Another challenge that was faced was a shortage of PPE for health workers resulting in workers either using torn PPE or working without them [97]. There was an increase in home deaths by those who are critically ill with Covid-19 or other diseases because they were afraid of going to public hospitals [47, 98]. The South African public has grown a large sense of trust in private hospitals which led to private hospitals reaching their maximum capacity resulting in patients being transferred to public hospitals [98]. There was limited access to COVID-19 patients and other patients in hospitals during the early policy response. However, these policies were eased to allowing one visitor at a time for fifteen minutes whilst observing NPIs [99].

Covid-19 and the policies formulated to help reduce the spread of the SARS-CoV-2 had adverse effects on the South African economy, more especially on Micro Small and Medium Enterprises (MSMEs) and informal workers and their households. The largest impact was the sudden loss of demand and revenue for Small and Medium Enterprises (SMEs) causing liquidity shortages [100, 101]. Additionally, since SMEs are labour-intensive they were exposed to disruption during lockdowns where their workforces are required to quarantine [100]. To keep the economy from crumbling, the Government of South Africa presented the government’s Economic Reconstruction and Recovery Plan (ERRP) to help restore the economy [102]. This COVID-19 stimulus package, which was announced on April 21, 2020, amounted to 10 per cent of the country’s GDP ($26 Billion). The stimulus package would be directed to help the health sector municipalities that provide basic services, wage protection through the Unemployment Insurance Fund (UIF), financial support for SMEs, and the credit guarantee scheme [102].

Conclusions

The early COVID-19 NPI policies implemented by the South African government were largely focused on reducing contact between individuals within the South African population. The NPIs implemented by the South African government were effective in reducing movement in South African locations. The adjustments to the National Lockdown Alert Level 3 policy resulted in a reduction in the peak total COVID-19 infections by 68.3% and the peak of the first epidemic wave was delayed by 84 days. The estimated effective COVID-19 reproductive number in the first COVID epidemic wave in South Africa was between 1.98 to 0.40. if no COVID-19 NPI policies were implemented in South Africa, the estimated COVID-19 herd immunity required in South Africa would be 79%.

Most COVID-19 patients admitted in South African hospitals during the first COVID-19 epidemic wave were admitted to the general ward. The mean COVID-19 patient discharge rate in the first COVID-19 epidemic wave in South Africa was 11.9 days per patient. The mean COVID-19 patient case fatality rate (CFR) in hospital and outside the hospital was 2.06%, 95% CI [1.86–2.25] (deaths per admitted patients) and 2.30%, 95% CI [1.12–3.83](deaths per severe and critical cases) respectively. The COVID-19 CFR outside the hospital was observed to be higher than in the hospital. There was a relatively low incidence of COVID-19 hospitalisation and deaths in children in South Africa. The risk of dying from COVID-19 in South African hospitals for age groups over 20 years approximately doubled with an increase in age of 10 years. There were indications of good clinical management and some level of preparedness by the South African healthcare system for the first COVID-19 epidemic wave. The COVID-19 disease or epidemic did not account for the majority of the natural deaths occurring in South Africa during the first COVID-19 epidemic wave highlighting the high disease burden in South Africa.

South African COVID-19 cases had a linear positive correlation with COVID-19 testing and were underreported due to limited COVID-19 testing capacity as well as the ability to identify COVID-19 symptomatic and asymptomatic cases. Most of the COVID-19 modelling done in South Africa during the first COVID-19 epidemic wave were variations of the SEIR model. Both proactive and semi-reactive COVID-19 models, using age-disease deterministic or country-specific regression of epidemiological data, were accurate in predicting the progression of the first COVID-19 epidemic wave in South Africa. The results from this study show that the COVID-19 NPI policies implemented by the Government of South Africa played a significant role in the reduction of COVID-19 active, hospitalised cases and deaths in South Africa’s first COVID-19 epidemic wave. The results also show the use of COVID-19 modelling to understand the COVID-19 pandemic and the impact of regressor variables in an epidemic.

Availability of data and materials

Data and Materials for this study will be shared under the supplementary material in the publication. Data and Materials relevant to this study which falls under the ARI COVID-19 Project are also publicly available on the ARI website: https://www.afrikanresearchinitiative.com/gallery.

References

  1. Hethcote HW. Three basic epidemiological models. 1989. p. 119–44.

    Google Scholar 

  2. WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it. @2020 WHO. 2020 [cited 22 June 2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.

  3. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status. Mil Med Res Military Medical Research. 2020;7:1–10.

    CAS  Google Scholar 

  4. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91–8. https://doi.org/10.1016/j.jare.2020.03.005. THE AUTHORS.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). WHO-China Jt Mission Coronavirus Dis 2019. 2020;1:40. Available from: https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)%0A, https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.

  6. Zheng J. SARS-coV-2: An emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16:1678–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. WHO. Rolling updates on coronavirus disease (COVID-19) [Internet]. 2020 WHO. 2020 [cited 22 June 2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.

  8. Mahmoud IS, Jarrar YB, Alshaer W, Ismail S. SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention. Biochimie. 2020; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258854/pdf/main.pdf.

  9. WHO. What we know about the COVID-19 immune response the latest on COVID-19 immunity & the current global situation. EPI-WIN. Geneva, Switzerland; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update-34-immunity-2nd.pdf?sfvrsn=8a488cb6_2.

  10. Gaythorpe K, Imai N, Cuomo-dannenburg G, Baguelin M, Bhatia S, Boonyasiri A, et al. Symptom progression of COVID-19. London: Imp Coll London COVID-19 Response Team; 2020. p. 1–10. https://doi.org/10.25561/77344.

  11. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395:497–506.

    Article  CAS  PubMed  Google Scholar 

  12. WHO. Clinical management : Living guidance COVID-19. World Heal Organ [Internet]. 2021; Available from: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-clinical-2021-1

  13. Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr Clin Res Rev. 2020;14:407–12.

    Article  Google Scholar 

  14. Mahal BA, Alshalalfa M, Kensler KH, Chowdhury-Paulino I, Kantoff P, Mucci LA, et al. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19. N Engl J Med. 2020;383:1083–5. https://doi.org/10.1056/NEJMc2025179.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Havers FP, Reed C, Lim T, Montgomery JM, Klena JD, Hall AJ, et al. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020;30329:1–11.

    Google Scholar 

  16. Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:1–6.

    Google Scholar 

  17. CDC. About COVID-19 Variants. Centers Dis. Control Prev. 2021 [cited 28 Feb 2020]. p. 1. Available from: https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant.html#print.

  18. WHO. SARS-CoV-2 Variants. Dis Outbreak News. Georgia Station; 2020 Dec 31;1. Available from: https://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/.

  19. Mkhize Z. First case of COVID-19 coronavirus reported in SA. Cape Town, South Africa; 2020. Available from: https://www.nicd.ac.za/first-case-of-covid-19-coronavirus-reported-in-sa/.

  20. NICD. Update on Covid-19 (01st October 2020). Media Statements,. 2020. p. 1 October 2020.

  21. Perra N. Non-pharmaceutical interventions during the COVID-19 pandemic: A review. Phys Rep. 2021;913:1–52 Elsevier B.V..

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. CDC. Nonpharmaceutical Interventions (NPIs) [Internet]. Centers Dis. Control Prev. 2020 [cited 18 Dec 2020]. p. 1. Available from: https://www.cdc.gov/nonpharmaceutical-interventions/index.html.

  23. Mengel MA, Delrieu I, Heyerdahl L, Gessner BD. Cholera Outbreaks in Africa Martin. Berlin: Curr. Top. Microbiol. Immunol; 2014.

    Google Scholar 

  24. Kweyu KZ, Owuor RA, Mwita CC. Needle and syringe programs for reducing blood-borne diseases among people who inject drugs in sub-Saharan Africa: a scoping review protocol. JBI Evid Synth. 2022;20:2512–8.

    Article  PubMed  Google Scholar 

  25. Shrivastava SR, Shrivastava PS, Ramasamy J. Ebola disease: Infection prevention and control in hospital and community settings. Iran J Nurs Midwifery Res. 2015;20:526–7.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Markel H, Stern AM, Navarro JA, Michalsen JR, Monto AS, DiGiovanni C. Nonpharmaceutical influenza mitigation strategies, US communities, 1918–1920 pandemic. Emerg Infect Dis. 2006;12:1961–4.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Government of South Africa. President Cyril Ramaphosa: Escalation of measures to combat Coronavirus COVID-19 pandemic. 2020 [cited 6 Jul 2020]. Available from: https://www.gov.za/speeches/president-cyril-ramaphosa-escalation-measures-combat-coronavirus-covid-19-pandemic-23-mar.

  28. Mahmud A, Lim PY. Applying the SEIR model in forecasting the COVID-19 trend in malaysia: A preliminary study. medRxiv. 2020. https://doi.org/10.1101/2020.04.14.20065607.

  29. Binti Hamzah FA, Lau CH, Nazri H, Ligot DC, Lee G, Tan CL, et al. CoronaTracker: World-wide Covid-19 outbreak data analysis and prediction. Bull World Health Organ. 2020;1–8:7–13.

  30. Craig J, Kalanxhi E, Osena G, Frost I. Estimating critical care capacity needs and gaps in Africa during the COVID-19 pandemic. medRxiv Prepr. 2020;1–11. https://doi.org/10.1101/2020.06.02.20120147v1.full.pdf.

  31. Ferguson NM, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. London; 2020. Available from: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf.

  32. Frost I, Craig J, Osena G, Hauck S, Kalanxhi E, Schueller E, et al. Modeling COVID-19 Transmission in Africa: Country-wise Projections of Total and Severe Infections Under Different Lockdown Scenarios. medRxiv. 2020; https://doi.org/10.1101/2020.09.04.20188102v1.

  33. Mukandavire Z, Malunguza NJ, Cuadros DF, Shiri T, Musuka G, Nyabadza F. Quantifying Early COVID-19 Outbreak Transmission in South Africa and Exploring Vaccine Efficacy Scenarios. SSRN Electron J. 2020;1–19.

  34. SACMC. Estimating cases for COVID-19 in South Africa. 2020. Available from: https://www.nicd.ac.za/wp-content/uploads/2020/05/SACMC_19052020_slides-for-MoH-media-briefing.pdf.

  35. Van Wees J, Osinga S, Van Der Kuip M, Tanck M, Hanegraaf M, Pluymaekers M, et al. Forecasting hospitalization and ICU rates of the COVID-19 outbreak : an efficient SEIR model. 2020.

    Google Scholar 

  36. Walker PGT, Whittaker C, Watson O, Baguelin M, Ainslie KEC, Bhatia S, et al. The Global Impact of COVID-19 and Strategies for Mitigation and Suppression. London; 2020. Available from: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Global-Impact-26-03-2020v2.pdf.

  37. Government of South Africa. COVID-19 models. 2020 [cited 15 Dec 2020]. Available from: https://www.gov.za/covid-19/models/covid-19-models.

  38. South African COVID-19 Modelling Consortium. Estimating cases for COVID-19 in South Africa Long-term national projections. 2020. Available from: https://www.heroza.org/publications/estimating-cases-for-covid-19-in-south-africa-long-term-national-projections-report-update-6-may-2020/.

  39. StatsSA. Statistical Release P0302: Mid-year population estimates 2020. South Africa: Stats SA. Pretoria; 2020.

    Google Scholar 

  40. NICD. Monthly Covid-19 in children surveillance report epidemiology and clinical characteristics of laboratory- monthly Covid-19 in children surveillance report. Cape Town, South Africa; 2020.

  41. UN. World Population Prospects 2019: Data Booklet. Dep. Econ. Soc. Aff. Popul. Div. 2019. Available from: https://population.un.org/wpp/Publications/Files/WPP2019_DataBooklet.pdf.

  42. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;6736:1–15.

    Google Scholar 

  43. Jassat W, Cohen C, Kufa T, Goldstein S, Masha M, Cowper B, et al. DATCOV: A sentinel surveillance programme for hospitalised individuals with covid-19 in South Africa, 2020. Johannesburg; 2020. Available from: https://www.nicd.ac.za/diseases-a-z-index/covid-19/surveillance-reports/.

  44. NICD. Daily hospital surveillance (DATCOV) REPORT. Dly. Hosp. Surveill. Rep. 2022 [cited 18 Aug 2022]. Available from: https://www.nicd.ac.za/diseases-a-z-index/covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/.

  45. WHO. Estimating mortality from COVID-19. 2020.

    Google Scholar 

  46. Aron J, Muellbauer J, Thinking NE, Giattino C, Ritchie H, World O. A pandemic primer on excess mortality statistics and their comparability across countries. 2020.

  47. Bradshaw D, Laubscher R, Dorrington R, Groenewald P, Moultrie T. Report on Weekly Deaths in South Africa 1 JANUARY – 4 AUGUST 2020 (WEEK 31). Cape Town: SAMRC; 2020. Available from: https://www.samrc.ac.za/reports/report-weekly-deaths-south-africa.

  48. SAMRC. Report on Weekly Deaths in South Africa. South Africa Med. Res. Counc. 2020 [cited 16 Dec 2020]. p. 1. Available from: https://www.samrc.ac.za/reports/report-weekly-deaths-south-africa.

  49. Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ. 2020;369:m1375. https://doi.org/10.1136/bmj.m1375.

    Article  PubMed  Google Scholar 

  50. Inui S, Fujikawa A, Jitsu M, Kunishima N, Watanabe S, Suzuki Y, et al. Chest CT Findings in Cases from the Cruise Ship “Diamond Princess” with Coronavirus Disease 2019 (COVID-19) Shohei. 2020;2019. https://doi.org/10.1148/ryct.2020200110.

  51. Sutton D, Fuchs K, D’Alton M, Goffman D. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med. 2020;382:2163–4.

    Article  PubMed  Google Scholar 

  52. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of COVID-19 disease. medRxiv. 2020;2020.03.09.20033357. https://doi.org/10.1101/2020.03.09.20033357.

  53. Worldometer. Reported Cases and Deaths by Country, Territory, or Conveyance. 2020 [cited 4 Sep 2020]. Available from: https://www.worldometers.info/coronavirus/.

  54. Byrne AW, Mcevoy D, Collins ÁB, Hunt K, Casey M, Barber A. Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases. 2020.

    Google Scholar 

  55. Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic Transmission of SARS-CoV-2 — Singapore. 2020;69:411–5.

  56. JHU CSSE. Novel Coronavirus (COVID-19) Cases Data [Internet]. Johns Hopkins Univ. Cent. Syst. Sci. Eng. (JHU CCSE). 2022 [cited 18 Aug 2022]. p. 1. Available from: https://data.humdata.org/dataset/novel-coronavirus-2019-ncov-cases.

  57. Government of South Africa. Disaster Management Act (57/2002): Regulations made in terms of Section 27(2) by the Minister of Cooperative Governance and Traditional Affairs. Gov Gaz. 2020; Available from: https://www.justice.gov.za/legislation/notices/2020/20200325-gg43148-GoN398-COVID19-COGTA.pdf.pdf.

  58. Arndt C, Davies R, Gabriel S, Harris L, Makrelov K, Robinson S, et al. Impact of Covid-19 on the South African Economy - An Initial Analysis. Tokyo: SA-TIED Work Pap 111; 2020.

  59. Government of South Africa. Alert Level 5. Pretoria; 2020. Available from: https://www.gov.za/documents/disaster-management-act-regulations-address-prevent-and-combat-spread-coronavirus-covid-19.

  60. Government of South Africa. Alert Level 4. Pretoria; 2020. Available from: https://www.gov.za/coronavirus/alert-level-4.

  61. Government of South Africa. Alert Level 3. Pretoria; 2020. Available from: https://www.gov.za/coronavirus/alert-level-3.

  62. Government of South Africa. Alert Level 2. Pretoria, South Africa; 2020. Available from: https://www.gov.za/coronavirus/alert-level-2#:~:text=Physical distancing and restrictions on, August to 20 September 2020.

  63. Government of South Africa. Alert Level 1. No. 44201 Government Gazette. Pretoria, South Africa. 2021. https://www.gov.za/sites/default/files/gcis_document/202103/44201rg11246gon152.pdf.

  64. Google. Google COVID-19 Community Mobility Reports. Community Mobil. Reports. 2020 [cited 2020 Jul 13]. p. 1. Available from: https://www.google.com/covid19/mobility/.

  65. NICD. COVID-19 testing summary South Africa week 40 2020 overview. Cape Town, South Africa; 2020. Available from: https://www.nicd.ac.za/wp-content/uploads/2020/10/COVID-19-Testing-Summary-Week-40-Oct-2020.pdf.

  66. GitHub. covid-19-data. covid-19-data. 2020 [cited 30 Nov 2020]. p. 1. Available from: https://github.com/owid/covid-19-data/blob/master/public/data/testing/covid-testing-all-observations.xlsx.

  67. Data Convergence. Provincial Breakdown of Corona Virus in South Africa. South Africa Prov. Break. 2020 [cited 16 June 2021]. p. 1. Available from: https://www.covid19sa.org/provincial-breakdown.

  68. Matzopoulos R, Walls H, Cook S, London L. South Africa’s COVID-19 Alcohol Sales Ban: The Potential for Better Policy-Making. Int J Heal Policy Manag. 2020;X:1–2.

    Google Scholar 

  69. Stats SA. General Household Survey 2017. Pretoria, South Africa; 2017. Available from: https://www.statssa.gov.za/publications/P0318/P03182017.pdf.

  70. Kemp S. Digital 2020: South Africa. 2020. Available from: https://datareportal.com/reports/digital-2020-south-africa.

  71. CGCSA. Consumer goods council of South Africa (CGCSA) welcomes government decision to ensure uninterrupted supply of essential good and non-food products during shutdown. Johannesburg, South Africa; 2020. Available from: https://www.cgcsa.co.za/wp-content/uploads/2020/03/Media-statement_COVID-19-National-Shutdown-24-March-2020.pdf.

  72. Deloitte. COVID-19 Preparedness : A South African Perspective. 2020. Available from: https://www2.deloitte.com/content/dam/Deloitte/za/Documents/risk/South Africa COVID-19 Preparedness_March 2020.pdf

  73. Zitek T. The appropriate use of testing for Covid-19. West J Emerg Med. 2020;21:470–2.

    Article  PubMed  PubMed Central  Google Scholar 

  74. WHO. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. Geneva: World Health Organization; 2020.

  75. Mayne ES, Scott HL, Semete B, Julsing A, Jugwanth S, Mampeule N, et al. The role of serological testing in the SARS-CoV-2 outbreak. South African Med J. 2020;110:842–5.

    Article  CAS  Google Scholar 

  76. Reed T. Where can clients test in Southern Africa? South Africa’s Travel news by TNW. 14 Oct 2020;1. Available from: https://www.travelnews.co.za/article/where-can-clients-test-southern-africa.

  77. Hsiao M, Davies M-A, Kalk E, Hardie D, Naidoo M, Centner C, et al. SARS-COV-2 seroprevalence in the Cape Town metropolitan sub-districts after the peak of infections. COVID-19 Spec. Public Heal. Surveill. Bull. Cape Town, South Africa; 2020.

  78. Moonasar D, Pillay A, Leonard E, Naidoo R, Mngemane S, Ramkrishna W, et al. COVID-19: Lessons and experiences from South Africa’s first surge. BMJ Glob Heal. 2021;6:1–5.

    Google Scholar 

  79. Tegally H, Wilkinson E, Lessells RR, Giandhari J, Pillay S, Msomi N, et al. Major new lineages of SARS-CoV-2 emerge and spread in South Africa during lockdown. medRxiv. 2020;2020.10.28.20221143. https://doi.org/10.1101/2020.10.28.20221143.

  80. Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv. 2020;2:8–11.

  81. NICD. The initial and daily covid-19 effective reproductive number (R) in South Africa. Cape Town, South Africa; 2020. Available from: https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Effective-Reproductive-Number-in-South-Africa_week-38.pdf.

  82. Mendelson M, Boloko L, Boutall A, Cairncross L, Calligaro G, Coccia C, et al. Clinical management of COVID-19: Experiences of the COVID-19 epidemic from Groote Schuur Hospital, Cape Town, South Africa. S Afr Med J South Africa. 2020;110:973–81.

    Article  CAS  Google Scholar 

  83. Department Health of Republic of South Africa. Latest Vaccine Statistics [Internet]. sacoronavirus. 2022 [cited 18 Aug 2022]. p. 1. Available from: https://sacoronavirus.co.za/latest-vaccine-statistics/.

  84. COVID-19 IMT, COVID-19 response team, DATCOV teams. Epidemiology and Clinical Characteristics of Laboratory-Confirmed Cases of Covid-19 Aged ≤18 Years, South Africa, 3 March 2020–7 June 2020. Natl. Inst. Commun. Dis. In. NICD Website Natl. Inst. Commun. Dis. In. NICD Website Natl. Inst. Commun. Dis. Cape Town, South Africa; 2020. Available from: https://www.nicd.ac.za/wp-content/uploads/2020/07/Laboratory-confirmed-cases-of-COVID-19-aged-≤18-years.pdf.

  85. Davies M-A, Boulle A. COVID-19 Special Public Health Surveillance Bulletin: Risk of COVID-19 DEATH AMONG PEOPLE WITH HIV. Cape Town, South Africa; 2020. Available from: https://www.nicd.ac.za/diseases-a-z-index/covid-19/surveillance-reports/daily-surveillance-in-selected-hospitals/.

  86. United Nations Department of Economic and Social Affairs Population Division. World Population Prospects 2019. 2019. Available from: https://population.un.org/wpp/Download/Standard/Population/.

  87. WHO. South Africa NCD Profile. Geneva, Switzerland. 2016.

  88. Houreld K, Lewis D, McNeill R, Granados S. Virus exposes gaping holes in Africa’s health systems. Reuters Graph. 2020;1. Available from: https://graphics.reuters.com/HEALTH-CORONAVIRUS/AFRICA/yzdpxoqbdvx/.

  89. Frost BI, Osena G, Craig J, Hauck S, Kalanxhi E, Gatalo O, et al. COVID-19 in East Africa : National Projections of Exposed, Contagious, Symptomatic & Severe Cases Overview : COVID-19 in Africa. 2020.

    Google Scholar 

  90. Cacciapaglia G, Cot C, Sannino F. Second wave COVID-19 pandemics in Europe: a temporal playbook. Sci Rep. Nature Publishing Group UK. 2020;10:1–8. Available from: https://doi.org/10.1038/s41598-020-72611-5.

  91. Blumberg L, Frean J. COVID-19 second wave in South Africa. Cape Town, South Africa; 2020. Available from: https://www.nicd.ac.za/covid-19-second-wave-in-south-africa/.

  92. Chalmers V, May L. Computer code for Prof Lockdown’s model which predicted 500,000 would die from Covid-19 and inspired Britain’s “Stay Home” plan is a “mess which would get you fired in private industry” say data experts. MAILONLINE. 2020;1. Available from: https://www.dailymail.co.uk/news/article-8327641/Coronavirus-modelling-Professor-Neil-Ferguson-branded-mess-experts.html.

  93. Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584:257–61.

    Article  CAS  PubMed  Google Scholar 

  94. South African COVID-19 Modelling Consortium. Estimating cases for COVID-19 in South Africa: Assessment of alternative scenarios Report Report Update: 5 Sept 2020. 2020. Available from: https://www.nicd.ac.za/wp-content/uploads/2020/11/SACovidModellingReport_LongTermProjections_050920_final.pdf.

  95. NICD. COVID-19 Weekly Epidemiology Brief South Africa Week 49 2020. Cape Town, South Africa; 2020. Available from: https://www.nicd.ac.za/wp-content/uploads/2020/12/COVID-19-Weekly-Epidemiology-Brief-week-49_.pdf.

  96. Karim SA. The South African Response to the Pandemic. N Engl J Med. 2020;382:1–3.

    Google Scholar 

  97. Singh JA, Moodley K. Critical care triaging in the shadow of COVID-19: Ethics considerations. South African Med J. 2020;110:355–9.

    CAS  Google Scholar 

  98. Jordan B. Too afraid to go to public hospital, many are dying of Covid-19 at home. Johannesburg: TimesLive; 2021. p. 1.

  99. Masweneng K. Visiting hour restrictions at Gauteng hospitals eased. Johannesburg: News/South Africa; 2021. p. 1.

  100. Zeidy IA. Economic impact of covid-19 on micro, small and medium enterprises (msmes) in africa and policy options for mitigation. Common Mark. East. South. Africa. Nairobi. 2020.

  101. Resnick D, Spencer E, Siwale T. Informal traders and COVID-19 in Africa: An opportunity to strengthen the social contract. London: IGC Policy Br; 2020.

  102. Bhorat H, Köhler T. Lockdown economics in South Africa: Social assistance and the Ramaphosa stimulus package. White River: AFRICA Focus; 2020. p. 1.

Download references

Acknowledgements

ARI would like to thank the members of the ADDRG and ACMRG for their voluntary commitment to working on the ARI COVID-19 Research Project. We would like to thank Professor Tom Moultrie and Dr Sheetal P. Silal from the University of Cape Town for providing consultation in the early modelling phase of the ARI COVID-19 Research project. We acknowledge the work of the National Institute for Communicable Diseases (NICD), Western Cape Department of Health Provincial Health Data Centre (PHDC) and South African Medical Research Council (SAMRC) from which the ARI COVID-19 Projects draws a lot of its data from. Lastly, we want to salute the scientific community, governments, healthcare workers, and essential personnel in their response to the pandemic and we pay homage to those who have lost their lives due to the COVID-19 pandemic.

Funding

This study falls under the ARI COVID-19 Research Project of which the project is currently not funded.

Author information

Authors and Affiliations

Authors

Contributions

The ARI COVID-19 Model was developed by Thabo Mabuka. All authors contributed to validating the model in application to this study and the writing of sections in the manuscript. All authors were involved in the review of the manuscript.

Authors information

Not applicable.

Corresponding author

Correspondence to Thabo Mabuka.

Ethics declarations

Ethics approval and consent to participate

An internal ethical assessment was conducted within the Afrikan Research Initiative at the start of the ARI COVID-19 Research Project and no regional ethics approval was requested for this study. Data used in this study was obtained from public sources with an Open Data Licence. Data obtained from patient data was obtained anonymised from the public source following local regulations of the Protection of Personal Information Act (POPI Act) -POPIA in South Africa.

Consent for publication

Not applicable.

Competing interests

There were no competing interests in this study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mabuka, T., Ncube, N., Ross, M. et al. The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa. BMC Public Health 23, 1492 (2023). https://doi.org/10.1186/s12889-023-16162-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-023-16162-0

Keywords